1
|
Michel A, Vedrenne-Cloquet M, Kossorotoff M, Thy M, Levy R, Pouletty M, De Marcellus C, Grimaud M, Moulin F, Hully M, Simonnet H, Desguerre I, Renolleau S, Oualha M, Chareyre J. Neurologic Outcomes and Quality of Life in Children After Extracorporeal Membrane Oxygenation. Pediatr Crit Care Med 2024; 25:e158-e167. [PMID: 38088764 DOI: 10.1097/pcc.0000000000003419] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/08/2024]
Abstract
RATIONALE Use of life support with extracorporeal membrane oxygenation (ECMO) is associated with brain injury. However, the consequences of these injuries on subsequent neurologic development and health-related quality of life (HRQoL) are poorly described in children. OBJECTIVES The aim of this preliminary study was to describe short- and long-term neurologic outcomes in survivors of ECMO, as well as their HRQoL. DESIGN Retrospective identified cohort with contemporary evaluations. SETTING Necker Children's Hospital academic PICU. PATIENTS Forty survivors who underwent ECMO (October 2014 to January 2020) were included in follow-up assessments in May 2021. INTERVENTIONS None. MEASUREMENT AND MAIN RESULTS We first reviewed the outcomes of ECMO at the time of PICU discharge, which included a summary of neurology, radiology, and Pediatric Overall/Cerebral Performance Category (POPC/PCPC) scores. Then, in May 2021, we interviewed parents and patients to assess HRQoL (Pediatric Quality of Life Inventory [PedsQL]) and POPC/PCPC for children 3 years old or older, and Denver II test (DTII) for younger children. An evaluation of DTII in the youngest patients 1 year after ECMO decannulation was also added. Median age at ECMO was 1.4 years (interquartile range [IQR], 0.4-6 yr). Thirty-five children (88%) underwent a venoarterial ECMO. At PICU discharge, 15 of 40 patients (38%) had neurologic impairment. Assessment of HRQoL was carried out at median of 1.6 years (IQR, 0.7-3.3 yr) after PICU discharge. PedsQL scores were over 70 of 100 for all patients (healthy peers mean results: 80/100), and scores were like those published in patients suffering with chronic diseases. In May 2021, seven of 15 patients had a normal DTII, and 36 of 40 patients had a POPC/PCPC score less than or equal to 3. CONCLUSIONS None of our patients presented severe disability at long term, and HRQoL evaluation was reassuring. Considering the risk of neurologic impairment after ECMO support, a systematic follow-up of these high-risk survivor patients would be advisable.
Collapse
Affiliation(s)
- Alizée Michel
- Réanimation Medico-Chirurgicale Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
- Université de Paris, Paris, France
| | - Meryl Vedrenne-Cloquet
- Réanimation Medico-Chirurgicale Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
| | | | - Michaël Thy
- Réanimation Medico-Chirurgicale Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
| | - Raphaël Levy
- Radiologie Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
| | - Marie Pouletty
- Réanimation Medico-Chirurgicale Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
| | - Charles De Marcellus
- Réanimation Medico-Chirurgicale Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
| | - Marion Grimaud
- Réanimation Medico-Chirurgicale Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
| | - Florence Moulin
- Réanimation Medico-Chirurgicale Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
| | - Marie Hully
- Neurologie Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
| | - Hina Simonnet
- Service de Rééducation Pédiatrique Hôpital Trousseau, Paris, France
| | | | - Sylvain Renolleau
- Réanimation Medico-Chirurgicale Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
- Université de Paris, Paris, France
| | - Mehdi Oualha
- Réanimation Medico-Chirurgicale Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
- Université de Paris, Paris, France
| | - Judith Chareyre
- Réanimation Medico-Chirurgicale Pédiatrique, Hôpital Necker Enfants Malades, Paris, France
- Université de Paris, Paris, France
| |
Collapse
|
2
|
Welfringer-Morin A, Bataille P, Drummond D, Bellon N, Ingen-Housz-Oro S, Bonigen J, Schmartz S, Giraud-Kerleroux L, Moulin F, De Saint Blanquat L, Bremond-Gignac D, Hadj-Rabia S, Bodemer C. Comparison of idiopathic and drug-induced epidermal necrolysis in children. Br J Dermatol 2023; 189:631-633. [PMID: 37410549 DOI: 10.1093/bjd/ljad226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2023] [Revised: 06/30/2023] [Accepted: 08/05/2023] [Indexed: 07/08/2023]
Abstract
In this monocentric retrospective study in a French paediatric reference centre, children with idiopathic epidermal necrolysis (EN) had more severe disease than those with drug-induced EN during the acute stage. In our study, no EN was attributed to infection.
Collapse
Affiliation(s)
- Anne Welfringer-Morin
- Department of Paediatric Dermatology
- Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions (TOXIBUL), Paris, France
| | | | | | - Nathalia Bellon
- Department of Paediatric Dermatology
- Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions (TOXIBUL), Paris, France
| | - Saskia Ingen-Housz-Oro
- Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions (TOXIBUL), Paris, France
- Department of Dermatology, AP-HP, Henri Mondor Hospital, University Paris-Est Créteil EpidermE, Créteil, France
| | - Julie Bonigen
- Paediatric Intensive Care Unit, Necker-Enfants Malades Hospital, University Paris Cité, AP-HP, France
| | | | - Laura Giraud-Kerleroux
- Department of Dermatology, AP-HP, Henri Mondor Hospital, University Paris-Est Créteil EpidermE, Créteil, France
| | - Florence Moulin
- Paediatric Intensive Care Unit, Necker-Enfants Malades Hospital, University Paris Cité, AP-HP, France
| | - Laure De Saint Blanquat
- Paediatric Intensive Care Unit, Necker-Enfants Malades Hospital, University Paris Cité, AP-HP, France
| | - Dominique Bremond-Gignac
- Department of Ophthalmology, Necker-Enfants Malades Hospital, University Paris Cité, AP-HP, Paris, France
| | | | - Christine Bodemer
- Department of Paediatric Dermatology
- Reference Center for Toxic Bullous Dermatoses and Severe Drug Reactions (TOXIBUL), Paris, France
| |
Collapse
|
3
|
Schmartz S, Welfringer-Morin A, Le Bourgeois M, Delacourt C, Berteloot L, Rabia SH, Bellon N, Moulin F, Pouletty M, Garcelon N, Bodemer C, Drummond D. Respiratory complications in pediatric epidermal necrolysis: A retrospective study of 22 cases. J Am Acad Dermatol 2023; 89:857-859. [PMID: 37355226 DOI: 10.1016/j.jaad.2023.05.092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2022] [Revised: 04/29/2023] [Accepted: 05/21/2023] [Indexed: 06/26/2023]
Affiliation(s)
- Sophie Schmartz
- Department of Pediatric Pulmonology and Allergology, University Hospital Necker-Enfants Malades, Paris, France
| | - Anne Welfringer-Morin
- Department of Pediatric Dermatology, University Hospital Necker-Enfants Malades, Paris, France
| | - Muriel Le Bourgeois
- Department of Pediatric Pulmonology and Allergology, University Hospital Necker-Enfants Malades, Paris, France
| | - Christophe Delacourt
- Department of Pediatric Pulmonology and Allergology, University Hospital Necker-Enfants Malades, Paris, France; Faculté de médecine, Université de Paris, Paris, France
| | - Laureline Berteloot
- Department of Pediatric Imaging, University Hospital Necker-Enfants Malades, Paris, France
| | - Smail Hadj Rabia
- Department of Pediatric Dermatology, University Hospital Necker-Enfants Malades, Paris, France; Faculté de médecine, Université de Paris, Paris, France
| | - Nathalia Bellon
- Department of Pediatric Dermatology, University Hospital Necker-Enfants Malades, Paris, France
| | - Florence Moulin
- Department of Pediatric Intensive Care Unit, University Hospital Necker-Enfants Malades, Paris, France
| | - Marie Pouletty
- Department of Pediatric Intensive Care Unit, University Hospital Necker-Enfants Malades, Paris, France
| | - Nicolas Garcelon
- Department of Informatics, Imagine Institute, Paris Cité University, Paris, France
| | - Christine Bodemer
- Department of Pediatric Dermatology, University Hospital Necker-Enfants Malades, Paris, France; Faculté de médecine, Université de Paris, Paris, France
| | - David Drummond
- Department of Pediatric Pulmonology and Allergology, University Hospital Necker-Enfants Malades, Paris, France; Faculté de médecine, Université de Paris, Paris, France.
| |
Collapse
|
4
|
El Hajj R, Stanzelova A, de Marcellus C, Kossorotoff M, Remangeon F, Roux CJ, Touzé R, Toubiana J, Benaboud S, Oualha M, Moulin F, Collignon C. Severe atypical Lemierre syndrome caused by methicillin-sensitive Staphylococcus aureus: Two pediatric case reports. Arch Pediatr 2023:S0929-693X(23)00037-4. [PMID: 36990936 DOI: 10.1016/j.arcped.2023.02.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2022] [Accepted: 02/12/2023] [Indexed: 03/29/2023]
Abstract
BACKGROUND Lemierre syndrome is typically associated with ear, nose, and throat (ENT) infections caused by Fusobacterium necrophorum. Since 2002, cases of atypical Lemierre-like syndrome secondary to Staphylococcus aureus have been reported. CASES We report two pediatric cases of atypical Lemierre syndrome with a similar presentation: exophthalmia, absence of pharyngitis, metastatic lung infection, and intracranial venous sinus thrombosis. Both patients had a favorable outcome following treatment with antibiotics, anticoagulation, and corticosteroids. CONCLUSION Regular therapeutic monitoring of antibiotic levels helped to optimize antimicrobial treatment in both cases.
Collapse
Affiliation(s)
- R El Hajj
- Pediatrics, André Mignot Hospital, Versailles, France
| | - A Stanzelova
- Department of General Pediatrics and Pediatric Infectious Diseases, Necker-Enfants Malades University Hospital, Paris, France; Université de Paris Cité, Paris, France
| | - C de Marcellus
- Pediatric Intensive Care Unit, APHP University Hospital Necker-Enfants Malades, Paris, France
| | - M Kossorotoff
- Pediatric Neurology, APHP University Hospital Necker-Enfants Malades, Paris, France
| | - F Remangeon
- Université de Paris Cité, Paris, France; Pediatric Otorhinolaryngology Department, APHP, Hôpital Universitaire Necker-Enfants Malades, Paris, France
| | - C-J Roux
- Pediatric Radiology, APHP University Hospital Necker-Enfants Malades, Paris, France
| | - R Touzé
- Ophthalmology Department and Reference Center for Rare Ophthalmological Diseases (OPHTARA), AP-HP, University Hospital Necker-Enfants Malades, Paris, France; Université de Paris Cité, Paris, France
| | - J Toubiana
- Department of General Pediatrics and Pediatric Infectious Diseases, Necker-Enfants Malades University Hospital, Paris, France; Université de Paris Cité, Paris, France
| | - S Benaboud
- Pharmacology Department, Cochin Hospital, AP-HP Centre-Université de Paris, Paris, France
| | - M Oualha
- Université de Paris Cité, Paris, France; Pediatric Intensive Care Unit, APHP University Hospital Necker-Enfants Malades, Paris, France
| | - F Moulin
- Pediatric Intensive Care Unit, APHP University Hospital Necker-Enfants Malades, Paris, France
| | - C Collignon
- Pediatric Intensive Care Unit, APHP University Hospital Necker-Enfants Malades, Paris, France.
| |
Collapse
|
5
|
Tuchmann-Durand C, Roda C, Renard P, Mortamet G, Bérat CM, Altenburger L, de Larauz MH, Thevenet E, Cottart CH, Moulin F, Bouchereau J, Brassier A, Arnoux JB, Schiff M, Bednarek N, Lamireau D, Garros A, Mention K, Cano A, Finger L, Pelosi M, Brochet CS, Caccavelli L, Raphalen JH, Renolleau S, Oualha M, de Lonlay P. Systemic corticosteroids for the treatment of acute episodes of rhabdomyolysis in lipin-1-deficient patients. J Inherit Metab Dis 2023. [PMID: 36680547 DOI: 10.1002/jimd.12592] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/30/2022] [Revised: 01/13/2023] [Accepted: 01/19/2023] [Indexed: 01/22/2023]
Abstract
Mutations in the LPIN1 gene constitute a major cause of severe rhabdomyolysis (RM). The TLR9 activation prompted us to treat patients with corticosteroids in acute conditions. In patients with LPIN1 mutations, RM and at-risk situations that can trigger RM have been treated in a uniform manner. Since 2015, these patients have also received intravenous corticosteroids. We retrospectively compared data on hospital stays by corticosteroid-treated patients vs. patients not treated with corticosteroids. Nineteen patients were hospitalized. The median number of admissions per patient was 21 overall and did not differ when comparing the 10 corticosteroid-treated patients with the 9 patients not treated with corticosteroids. Four patients in the non-corticosteroid group died during a RM (mean age at death: 5.6 years). There were no deaths in the corticosteroid group. The two groups did not differ significantly in the number of RM episodes. However, for the six patients who had RM and occasionally been treated with corticosteroids, the median number of RM episodes was significantly lower when intravenous steroids had been administered. The peak plasma creatine kinase level and the area under the curve were or tended to be higher in patients treated with corticosteroids-even after the exclusion of deceased patients or focusing on the period after 2015. The median length of stay (10 days overall) was significantly longer for corticosteroid-treated patients but was similar after the exclusion of deceased patients. The absence of deaths and the higher severity of RM observed among corticosteroid-treated patients could suggest that corticotherapy is associated with greater survival.
Collapse
Affiliation(s)
- Caroline Tuchmann-Durand
- Imagine Institute, Biotherapy Clinical Investigation Center, Biotherapy Department, Necker-Enfants-Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - Célina Roda
- Université Paris Cité, Health Environmental Risk Assessment (HERA) Team, CRESS, INSERM, INRAE, Paris, France
- Faculté de Pharmacie de Paris, Université Paris Cité, Paris, France
| | - Perrine Renard
- INSERM U1151, Institut Necker Enfants-Malades (INEM), Paris, France
| | - Guillaume Mortamet
- Pediatric Intensive Care Unit, Grenoble Alpes University Hospital, Grenoble, France
| | - Claire-Marine Bérat
- Reference Center for Inherited Metabolic Diseases, Necker-Enfants-Malades University Hospital, APHP, Imagine Institute, G2M, MetabERN, Paris, France
| | - Lucile Altenburger
- Reference Center for Inherited Metabolic Diseases, Necker-Enfants-Malades University Hospital, APHP, Imagine Institute, G2M, MetabERN, Paris, France
| | - Marie Hug de Larauz
- Imagine Institute, Biotherapy Clinical Investigation Center, Biotherapy Department, Necker-Enfants-Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - Eloise Thevenet
- Imagine Institute, Biotherapy Clinical Investigation Center, Biotherapy Department, Necker-Enfants-Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - Charles-Henry Cottart
- Faculté de Pharmacie de Paris, Université Paris Cité, Paris, France
- Biochemistry Unit, Biology Department, Assistance Publique Hôpitaux de Paris (AP-HP), Necker-Enfants-Malades University Hospital, Paris, France
| | - Florence Moulin
- Pediatric Intensive Care Unit for, Necker-Enfants-Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - Juliette Bouchereau
- Reference Center for Inherited Metabolic Diseases, Necker-Enfants-Malades University Hospital, APHP, Imagine Institute, G2M, MetabERN, Paris, France
| | - Anais Brassier
- Reference Center for Inherited Metabolic Diseases, Necker-Enfants-Malades University Hospital, APHP, Imagine Institute, G2M, MetabERN, Paris, France
| | - Jean-Baptiste Arnoux
- Reference Center for Inherited Metabolic Diseases, Necker-Enfants-Malades University Hospital, APHP, Imagine Institute, G2M, MetabERN, Paris, France
| | - Manuel Schiff
- Reference Center for Inherited Metabolic Diseases, Necker-Enfants-Malades University Hospital, APHP, Imagine Institute, G2M, MetabERN, Paris, France
- Medical School, Université Paris Cité, Paris, France
| | - Nathalie Bednarek
- Intensive Care Unit and Competence Center for Inherited Metabolic Diseases, Reims University Hospital, Reims, France
| | - Delphine Lamireau
- Competence Center for Inherited Metabolic Diseases, Pellegrin University Hospital, Bordeaux, France
| | - Alexa Garros
- Competence Center for Inherited Metabolic Diseases, Grenoble Alpes University Hospital, Grenoble, France
| | - Karine Mention
- Reference Center for Inherited Metabolic Diseases, Jeanne de Flandre Hospital, MetabERN, Lille, France
| | - Aline Cano
- Reference Center for Inherited Metabolic Diseases, La Timone University Hospital, MetabERN, Marseille, France
| | - Lionel Finger
- Biochemistry Unit, Biology Department, Troyes Hospital, Troyes, France
| | - Michele Pelosi
- Reference Center for Inherited Metabolic Diseases, Necker-Enfants-Malades University Hospital, APHP, Imagine Institute, G2M, MetabERN, Paris, France
| | | | - Laure Caccavelli
- INSERM U1151, Institut Necker Enfants-Malades (INEM), Paris, France
- Reference Center for Inherited Metabolic Diseases, Necker-Enfants-Malades University Hospital, APHP, Imagine Institute, G2M, MetabERN, Paris, France
| | - Jean-Herlé Raphalen
- Adult Intensive Care Unit, Necker-Enfants-Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
| | - Sylvain Renolleau
- Pediatric Intensive Care Unit for, Necker-Enfants-Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
- Medical School, Université Paris Cité, Paris, France
| | - Mehdi Oualha
- Pediatric Intensive Care Unit for, Necker-Enfants-Malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France
- Medical School, Université Paris Cité, Paris, France
| | - Pascale de Lonlay
- INSERM U1151, Institut Necker Enfants-Malades (INEM), Paris, France
- Reference Center for Inherited Metabolic Diseases, Necker-Enfants-Malades University Hospital, APHP, Imagine Institute, G2M, MetabERN, Paris, France
- Medical School, Université Paris Cité, Paris, France
| |
Collapse
|
6
|
Collignon C, Frachette C, Callot D, Pinhas Y, Bataille P, Bader-Meunier B, Chouchana L, Frémond ML, Belhadjer Z, Oualha M, Moulin F, Javouhey E, Belot A, Renolleau S. Two pediatric cases of multisystem inflammatory-like syndrome following COVID-19 vaccination. Arch Pediatr 2022; 29:620-623. [PMID: 36283888 PMCID: PMC9510064 DOI: 10.1016/j.arcped.2022.08.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2022] [Revised: 06/23/2022] [Accepted: 08/25/2022] [Indexed: 11/25/2022]
Abstract
Multisystem inflammatory syndrome in children (MIS-C) is a novel post-infectious disease occurring in the context of SARS-CoV2 infection. COVID-19 vaccines have been authorized since December 2020, and adverse events including myocarditis have been reported following vaccination. We describe the cases of two pediatric patients presenting with clinical and laboratory features suggestive of MIS-C a few days after receiving their first dose of the Pfizer BNT162b2 vaccine. The outcome was favorable for both patients (after corticosteroid and immunoglobulin administration for one patient). These cases suggest an association between the COVID-19 vaccine and the occurrence of MIS-C.
Collapse
|
7
|
Ouldali N, Bagheri H, Salvo F, Antona D, Pariente A, Leblanc C, Tebacher M, Micallef J, Levy C, Cohen R, Javouhey E, Bader-Meunier B, Ovaert C, Renolleau S, Hentgen V, Kone-Paut I, Deschamps N, De Pontual L, Iriart X, Guen CGL, Angoulvant F, Belot A, Donzeau A, Aridi LE, Lety S, Leboucher B, Baur A, Jeusset L, Selegny M, Fedorczuk C, Lajus M, Bensaid P, Laoudi Y, Pons C, Robert AC, Beaucourt C, De Pontual L, Richard M, Goisque E, Iriart X, Brissaud O, Segretin P, Molimard J, Orecel MC, Benoit G, Bongiovanni L, Guerder M, Pouyau R, De Guillebon De Resnes JM, Mezgueldi E, Cour-Andlauer F, Horvat C, Poinsot P, Frachette C, Ouziel A, Gillet Y, Barrey C, Brouard J, Villedieu F, Ro V, Elanga N, Gajdos V, Basmaci R, Mutar H, Rouget S, Nattes E, Hau I, Biscardi S, Jurdi HE, Jung C, Semama D, Huet F, Zoccarato AM, Sarakbi M, Mortamet G, Bost-Bru C, Bassil J, Vinit C, Hentgen V, Leroux P, Bertrand V, Parrod C, Craiu I, Kone-Paut I, Durand P, Tissiere P, Claude C, Morelle G, Guiddir T, Borocco C, Delion F, Guillot C, Leteurtre S, Dubos F, Jouancastay M, Martinot A, Voeusler V, Languepin J, Garrec N, Demersay AC, Morand A, Bosdure E, Vanel N, Ughetto F, Michel F, Caujolle M, Blonde R, Nguyen J, Vignaud O, Masserot-Lureau C, Gouraud F, Araujo C, Ingrao T, Naji S, Sehaba M, Roche C, Carbasse A, Milesi C, Mazeghrane M, Haupt S, Schweitzer C, Romefort B, Launay E, Guen CGL, Ali A, Blot N, Tran A, Rancurel A, Afanetti M, Odorico S, Talmud D, Chosidow A, Romain AS, Grimprel E, Pouletty M, Gaschignard J, Corseri O, Faye A, Gaschignard J, Melki I, Ducrocq C, Benzoïd C, Lokmer J, Dauger S, Chomton M, Deho A, Lebourgeois F, Renolleau S, Lesage F, Moulin F, Dupic L, Pinhas Y, Debray A, Chalumeau M, Abadie V, Frange P, Cohen JF, Allali S, Curtis W, Belhadjer Z, Auriau J, Méot M, Houyel L, Bonnet D, Delacourt C, Meunier BB, Quartier P, Shaim Y, Baril L, Crommelynck S, Jacquot B, Blanc P, Maledon N, Robert B, Loeile C, Cazau C, Loron G, Gaga S, Vittot C, Nabhani LE, Buisson F, Prudent M, Flodrops H, Mokraoui F, Escoda S, Deschamps N, Bonnemains L, Mahi SL, Mertes C, Terzic J, Helms J, Idier C, Chenichene S, Ursulescu NM, Beaujour G, Hakim A, Miquel A, Rey A, Wiedermann A, Charbonneau A, Veauvy-Juven A, Ferry A, Mandelcwajg A, Rousseau A, Prenant A, Bourneuf AL, Filleron A, Robine A, Félix A, Parizel A, Labarre A, Cantais A, Ros B, Coulon B, Biot B, Dalichoux B, Fournier B, Cagnard B, Vanel B, Brossier D, Ménager B, Ozanne B, Marie-Jeanne C, Bergerot C, Chavy C, Guidon C, Fabre C, Galeotti C, Baker C, Ballot-Schmit C, Belleau C, Charasse C, Favel C, Toumi C, Ferrandiz C, Couturier C, Pouchoux C, Chomton-Cailliez M, Kevorkian-Verguet C, Brunet C, Manteau C, Mougey C, Santy C, Fitament C, Petriat C, Rebelle C, Charron C, Dartus M, Toulorge D, Guillou-Debuisson C, Bartebin D, Klein V, Broustal E, Desselas E, Marteau E, Bouvrot E, Delacroix E, Coinde E, Elnabhani L, Amouyal E, Chaillou E, Gabilly-Bernard E, Ruiz E, Thibault E, Robin E, Darrieux E, Blondel E, Socchi F, Cazassus F, Bajolle F, Lacin F, Madhi F, Zekre F, Guerin F, Boussicault G, Ginies H, Magloire G, Arnold G, Coulognon I, Sicard-Cras I, Kahn JE, Bordet J, Fausser JL, Baleine JF, Brice J, Gendras J, Pekin K, Norbert K, Karsenty C, Savary L, Martinat L, Lesniewski L, Charbonnier L, Alexandre L, Percheron L, Vincenti M, Selegny M, Lanzini M, Grisval M, Mercy M, Lampin ME, Desgranges M, Duperril M, Orcel MC, Audier M, Favier M, Carpentier M, Balcean M, Bonnet M, Jouret M, Delattre M, Levy M, Valensi M, Shum M, Dumortier M, Gelin M, Nemmouchi M, Williaume M, Sebaha M, Genetay-Stanescu N, Giroux N, Crassard N, Derridj N, Lachaume N, Werner O, Guilluy O, Richer O, Tirel O, Pauvert A, Casha P, Perez N, Gras P, Leger PL, Pinchou M, Mornand P, Largo P, Ibanez RC, Roulland C, Albarazi SH, Bichali S, Faton S, Schott A, Walser S, Guillaume S, Vincent S, Galene-Gromez S, Kozisek S, Maugard T, Blanc T, Navarro T, Lauvray T, Kovacs T, Launay V, Despert V, Lhostis V, Gall V, Micaelli X, Benadjaoud Y, Matoussi Z, Géniaux H, Facile A, Pietri T, Palassin P, Pinel S, Chouchana L, Callot D, Boulay C. Correction to “Hyper inflammatory syndrome following COVID-19 mRNA vaccine in children: A national post-authorization pharmacovigilance study”. Lancet Reg Health Eur 2022. [PMID: 35967266 PMCID: PMC9364716 DOI: 10.1016/j.lanepe.2022.100468] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
8
|
Fourgeaud J, Toubiana J, Chappuy H, Delacourt C, Moulin F, Parize P, Scemla A, Abid H, Leruez-Ville M, Frange P. No durable impact of COVID-19 measures on the hospital burden of Respiratory Syncytial Virus (France, 2018-2022). J Infect 2022; 85:436-480. [PMID: 35760301 PMCID: PMC9233884 DOI: 10.1016/j.jinf.2022.06.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2022] [Revised: 06/13/2022] [Accepted: 06/20/2022] [Indexed: 11/18/2022]
Affiliation(s)
- Jacques Fourgeaud
- Laboratoire de microbiologie clinique, Hopital Necker - Enfants malades, Groupe hospitalier Assistance Publique - Hôpitaux de Paris (AP-HP).Centre - Université Paris Cité, Paris, France.; EHU 7327, Institut Imagine, Université de Paris, Paris, France.; CNR Cytomegalovirus, Laboratoire associé, Hôpital Necker-Enfants malades, Paris, France
| | - Julie Toubiana
- Service de Pédiatrie générale et Maladies infectieuses, Hôpital Necker - Enfants malades, Groupe hospitalier AP-HP.Centre - Université Paris Cité, Paris, France.; CNR de la Coqueluche et autres Bordetelloses, Unité « Biodiversité et épidémiologie des bactéries pathogènes », Institut Pasteur, Paris, France
| | - Hélène Chappuy
- Service d'Urgences pédiatriques, Hôpital Necker - Enfants malades, Groupe hospitalier AP-HP.Centre - Université Paris Cité, Paris, France.; EA7323, Université Paris Cité, Paris, France
| | - Christophe Delacourt
- Service de pneumologie et allergologie pédiatriques, Hôpital Necker - Enfants malades, Groupe hospitalier AP-HP.Centre - Université Paris Cité, Paris, France
| | - Florence Moulin
- Service de Réanimation et surveillance continue médico-chirurgicale pédiatrique, Hôpital Necker Enfants-Malades, Groupe hospitalier AP-HP.Centre - Université Université Paris Cité, Paris, France
| | - Perrine Parize
- Service de Maladies infectieuses et tropicales, Hôpital Necker - Enfants malades, Groupe hospitalier AP-HP.Centre -Université Paris Cité, Paris. France
| | - Anne Scemla
- Service de Néphrologie - Transplantation, Hôpital Necker-Enfants malades, Groupe hospitalier AP-HP.Centre - Université Paris Cité, Paris, France.; RTRS Centaure, Labex Transplantex, Université Paris Cité, France
| | - Hanene Abid
- Laboratoire de microbiologie clinique, Hopital Necker - Enfants malades, Groupe hospitalier Assistance Publique - Hôpitaux de Paris (AP-HP).Centre - Université Paris Cité, Paris, France
| | - Marianne Leruez-Ville
- Laboratoire de microbiologie clinique, Hopital Necker - Enfants malades, Groupe hospitalier Assistance Publique - Hôpitaux de Paris (AP-HP).Centre - Université Paris Cité, Paris, France.; EHU 7327, Institut Imagine, Université de Paris, Paris, France.; CNR Cytomegalovirus, Laboratoire associé, Hôpital Necker-Enfants malades, Paris, France
| | - Pierre Frange
- Laboratoire de microbiologie clinique, Hopital Necker - Enfants malades, Groupe hospitalier Assistance Publique - Hôpitaux de Paris (AP-HP).Centre - Université Paris Cité, Paris, France.; EHU 7327, Institut Imagine, Université de Paris, Paris, France..
| |
Collapse
|
9
|
Rossi M, Durrleman C, Hayat M, Roux CJ, Kossorotoff M, Gitiaux C, Mazuet C, Moulin F, Collignon C. Infant botulism: Report of a misleading case and important key messages. Arch Pediatr 2022; 29:395-397. [DOI: 10.1016/j.arcped.2022.05.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2021] [Revised: 03/28/2022] [Accepted: 05/12/2022] [Indexed: 11/28/2022]
|
10
|
de Cacqueray N, Boujaafar S, Bille E, Moulin F, Gana I, Benaboud S, Hirt D, Béranger A, Toubiana J, Renolleau S, Tréluyer JM, Oualha M. Therapeutic Drug Monitoring of Antibiotics in Critically Ill Children: An Observational Study in a Pediatric Intensive Care Unit. Ther Drug Monit 2022; 44:319-327. [PMID: 35292609 DOI: 10.1097/ftd.0000000000000918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2021] [Accepted: 07/05/2021] [Indexed: 11/26/2022]
Abstract
BACKGROUND Septic critically ill children are at a high risk of inadequate antibiotic exposure, requiring them to undergo therapeutic drug monitoring (TDM). The aim of this study was to describe the use of TDM for antibiotics in critically ill children. METHODS The authors conducted a single-center observational study between June and December 2019, with all children treated with antibiotics in a pediatric intensive care unit located in a French university hospital. Standard clinical and laboratory data were recorded. Blood samples were collected for routine laboratory tests, and plasma antibiotic levels were assayed using validated analytical methods. RESULTS A total of 209 children received antibiotics. TDM was performed in 58 patients (27.8%) who had a greater mean organ dysfunction (according to the International Pediatric Sepsis Consensus Conference) (3 versus 1 in the non-TDM group; P < 0.05) and were treated with antibiotics for longer. A total of 208 samples were analyzed. The median [interquartile range] assay turnaround time was 3 (1-5) days, and 48 (46.2%) of the 104 initial antibiotic concentration values were below the pharmacokinetic/pharmacodynamic targets. A total of 34 (46%) of the 74 off-target TDM measurements available before the end of the antibiotic treatment prompted dose adjustment. This dose adjustment increased the proportion of on-target TDM measurements (70% versus 20% without adjustment). Subsequent measurements of the minimum inhibitory concentration showed that the use of the European Committee on Antimicrobial Susceptibility Testing's epidemiological cutoff values led to underestimation of pharmacokinetic/pharmacodynamic target attainment in 10 cases (20%). CONCLUSIONS TDM seems to be an effective means of optimizing antibiotic exposure in critically ill children. This requires timely plasma antibiotic assays and minimum inhibitory concentration measurements. It is important to define which patients should undergo TDM and how this monitoring should be managed.
Collapse
Affiliation(s)
- Noémie de Cacqueray
- Department of Pediatric Intensive Care Unit, Necker Enfants Malades Hospital, Université de Paris
| | - Sana Boujaafar
- Department of Clinical Pharmacology, Cochin Hospital, Université de Paris
- Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Université de Paris
| | - Emmanuelle Bille
- Microbiological Laboratory, Necker Enfants Malades Hospital, Université de Paris; and
| | - Florence Moulin
- Department of Pediatric Intensive Care Unit, Necker Enfants Malades Hospital, Université de Paris
| | - Inès Gana
- Department of Clinical Pharmacology, Cochin Hospital, Université de Paris
- Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Université de Paris
| | - Sihem Benaboud
- Department of Clinical Pharmacology, Cochin Hospital, Université de Paris
- Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Université de Paris
| | - Déborah Hirt
- Department of Clinical Pharmacology, Cochin Hospital, Université de Paris
- Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Université de Paris
| | - Agathe Béranger
- Department of Pediatric Intensive Care Unit, Necker Enfants Malades Hospital, Université de Paris
- Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Université de Paris
| | - Julie Toubiana
- Department of General Pediatrics and Pediatric Infectious Diseases, Necker Enfants Malades Hospital, Université de Paris, Paris, France
| | - Sylvain Renolleau
- Department of Pediatric Intensive Care Unit, Necker Enfants Malades Hospital, Université de Paris
| | - Jean M Tréluyer
- Department of Pediatric Intensive Care Unit, Necker Enfants Malades Hospital, Université de Paris
- Department of Clinical Pharmacology, Cochin Hospital, Université de Paris
- Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Université de Paris
| | - Mehdi Oualha
- Department of Pediatric Intensive Care Unit, Necker Enfants Malades Hospital, Université de Paris
- Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Université de Paris
| |
Collapse
|
11
|
Galéra C, Moulin F, Melchior M, Rouquette A. Symptoms of emotional difficulties and hyperactivity/inattention among children during the COVID-19 epidemic and associated lockdown: data from the SAPRIS project. Eur J Public Health 2021. [DOI: 10.1093/eurpub/ckab164.235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
COVID-19 limitation strategies led to widespread school closures around the world. The present study aims to provide a description of children's mental health and associated factors during the COVID-19 school closure in France.
Methods
We conducted a cross-sectional analysis in the SAPRIS study during the COVID-19 pandemic in France, relying on 2 ongoing national birth cohorts, ELFE and EPIPAGE 2. Using weighted multinomial logistic regression models, we estimated associations between children's mental health (i.e., hyperactivity/inattention and emotional symptoms; assessed by the Strengths and Difficulties Questionnaire), children's health behaviors, schooling, as well as sociodemographic and socioeconomic characteristics of children family.
Results
The sample consisted of 5702 children aged 8 - 9 years and 49.3% girls. Sleep disturbance and parents' dominant socio-professional category were associated with both hyperactivity-inattention (adjusted Odds Ratio (aOR)=2.10 95%Confidence Interval [1.85-2.38]; aOR=0.45 [0.33-0.61] respectively) and emotional symptoms and (aOR=6.33 [5.26-7.63]; aOR=0.62 [0.39-0.98] respectively). Specifically associated with hyperactivity/inattention were: male sex (aOR=2.51 [2.24-2.82]), presence of regular care and its pursuit during school closure (aOR=1.69 [1.33-2.15]), emotional symptoms (aOR=2.74 [2.23-3.37]), school situation (aOR=2.19 [1.69-2.82]), presence of tutoring and difficulties with it (aOR=2.56 [2.13-3.08]), type of housing (aOR=0.79 [0.70-0.89]). Factors associated with emotional symptoms were: presence of covid cases in the household (aOR=2.33 [1.92-2.82]), hyperactivity/inattention (aOR=2.94 [2.45-3.52]) and financial difficulties (aOR=1.71 [1.39-2.11]).
Conclusions
Policy makers need to balance pros and cons of closing schools, taking into consideration educational and psychological consequences for children and the various factors associated with mental health.
Collapse
Affiliation(s)
- C Galéra
- INSERM, U 1219, Bordeaux Population Health Research Center, Bordeaux, France
- Université de Bordeaux, Bordeaux, France
- Centre Hospitalier Charles Perrens, Department of Child and Adolescent Psychiatry, Bordeaux, France
| | - F Moulin
- INSERM, U 1219, Bordeaux Population Health Research Center, Bordeaux, France
| | - M Melchior
- INSERM Sorbonne Université, IPLESP, ERES, UMRS 1136, Paris, France
| | - A Rouquette
- Université Paris-Saclay, UVSQ, Inserm, CESP, Paris, France
| |
Collapse
|
12
|
de Cevins C, Luka M, Smith N, Meynier S, Magérus A, Carbone F, García-Paredes V, Barnabei L, Batignes M, Boullé A, Stolzenberg MC, Pérot BP, Charbit B, Fali T, Pirabakaran V, Sorin B, Riller Q, Abdessalem G, Beretta M, Grzelak L, Goncalves P, Di Santo JP, Mouquet H, Schwartz O, Zarhrate M, Parisot M, Bole-Feysot C, Masson C, Cagnard N, Corneau A, Brunaud C, Zhang SY, Casanova JL, Bader-Meunier B, Haroche J, Melki I, Lorrot M, Oualha M, Moulin F, Bonnet D, Belhadjer Z, Leruez M, Allali S, Gras-Leguen C, de Pontual L, Fischer A, Duffy D, Rieux-Laucat F, Toubiana J, Ménager MM. A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis. Med (N Y) 2021; 2:1072-1092.e7. [PMID: 34414385 PMCID: PMC8363470 DOI: 10.1016/j.medj.2021.08.002] [Citation(s) in RCA: 30] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2021] [Revised: 05/12/2021] [Accepted: 08/09/2021] [Indexed: 12/28/2022]
Abstract
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children is generally milder than in adults, but a proportion of cases result in hyperinflammatory conditions often including myocarditis. Methods To better understand these cases, we applied a multiparametric approach to the study of blood cells of 56 children hospitalized with suspicion of SARS-CoV-2 infection. Plasma cytokine and chemokine levels and blood cellular composition were measured, alongside gene expression at the bulk and single-cell levels. Findings The most severe forms of multisystem inflammatory syndrome in children (MIS-C) related to SARS-CoV-2 that resulted in myocarditis were characterized by elevated levels of pro-angiogenesis cytokines and several chemokines. Single-cell transcriptomics analyses identified a unique monocyte/dendritic cell gene signature that correlated with the occurrence of severe myocarditis characterized by sustained nuclear factor κB (NF-κB) activity and tumor necrosis factor alpha (TNF-α) signaling and associated with decreased gene expression of NF-κB inhibitors. We also found a weak response to type I and type II interferons, hyperinflammation, and response to oxidative stress related to increased HIF-1α and Vascular endothelial growth factor (VEGF) signaling. Conclusions These results provide potential for a better understanding of disease pathophysiology. Funding Agence National de la Recherche (Institut Hospitalo-Universitaire Imagine, grant ANR-10-IAHU-01; Recherche Hospitalo-Universitaire, grant ANR-18-RHUS-0010; Laboratoire d’Excellence ‘‘Milieu Intérieur,” grant ANR-10-LABX-69-01; ANR-flash Covid19 “AIROCovid” and “CoVarImm”), Institut National de la Santé et de la Recherche Médicale (INSERM), and the “URGENCE COVID-19” fundraising campaign of Institut Pasteur. Children with SARS-CoV-2 infection were initially thought to have only mild COVID-19 symptoms. However, several weeks into the first wave of SARS-CoV-2 infections, there was a surge of a postacute pathology called multisystem inflammatory syndrome in children (MIS-C). The authors recruited a cohort of children with suspicion of SARS-CoV-2 infection and uncovered hyperinflammation, hypoxic conditions, exacerbation of TNF-α signaling via NF-κB, and absence of responses to type I and type II IFN secretion in the most severe forms of MIS-C with severe myocarditis. This work led the authors to identify in monocytes and validate in peripheral blood mononuclear cells a molecular signature of 25 genes that allows discrimination of the most severe forms of MIS-C with myocarditis.
Collapse
Affiliation(s)
- Camille de Cevins
- Université de Paris, Imagine Institute, Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Atip-Avenir Team, INSERM UMR 1163, 75015 Paris, France
- Molecular Biology and Genomics, Translational Sciences, Sanofi R&D, Chilly-Mazarin, France
| | - Marine Luka
- Université de Paris, Imagine Institute, Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Atip-Avenir Team, INSERM UMR 1163, 75015 Paris, France
- Labtech Single-Cell@Imagine, Imagine Institute, INSERM UMR 1163, 75015 Paris, France
| | - Nikaïa Smith
- Translational Immunology Lab, Department of Immunology, Institut Pasteur, 75015 Paris, France
| | - Sonia Meynier
- Université de Paris, Imagine Institute Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 75015 Paris, France
| | - Aude Magérus
- Université de Paris, Imagine Institute Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 75015 Paris, France
| | - Francesco Carbone
- Université de Paris, Imagine Institute, Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Atip-Avenir Team, INSERM UMR 1163, 75015 Paris, France
- Labtech Single-Cell@Imagine, Imagine Institute, INSERM UMR 1163, 75015 Paris, France
| | - Víctor García-Paredes
- Université de Paris, Imagine Institute, Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Atip-Avenir Team, INSERM UMR 1163, 75015 Paris, France
- Labtech Single-Cell@Imagine, Imagine Institute, INSERM UMR 1163, 75015 Paris, France
| | - Laura Barnabei
- Université de Paris, Imagine Institute Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 75015 Paris, France
| | - Maxime Batignes
- Université de Paris, Imagine Institute, Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Atip-Avenir Team, INSERM UMR 1163, 75015 Paris, France
| | - Alexandre Boullé
- Université de Paris, Imagine Institute, Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Atip-Avenir Team, INSERM UMR 1163, 75015 Paris, France
| | - Marie-Claude Stolzenberg
- Université de Paris, Imagine Institute Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 75015 Paris, France
| | - Brieuc P Pérot
- Université de Paris, Imagine Institute, Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Atip-Avenir Team, INSERM UMR 1163, 75015 Paris, France
| | - Bruno Charbit
- Cytometry and Biomarkers UTechS, CRT, Institut Pasteur, 75015, Paris, France
| | - Tinhinane Fali
- Université de Paris, Imagine Institute, Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Atip-Avenir Team, INSERM UMR 1163, 75015 Paris, France
| | - Vithura Pirabakaran
- Université de Paris, Imagine Institute Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 75015 Paris, France
| | - Boris Sorin
- Université de Paris, Imagine Institute Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 75015 Paris, France
| | - Quentin Riller
- Université de Paris, Imagine Institute Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 75015 Paris, France
| | - Ghaith Abdessalem
- Université de Paris, Imagine Institute, Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Atip-Avenir Team, INSERM UMR 1163, 75015 Paris, France
| | - Maxime Beretta
- Humoral Immunology Laboratory, Department of Immunology, Institut Pasteur, 75015, Paris, France
- INSERM U1222, Institut Pasteur, 75015, Paris, France
| | - Ludivine Grzelak
- Virus and Immunity Unit, Department of Virology, Institut Pasteur, 75015, Paris, France
| | - Pedro Goncalves
- INSERM U1223, Institut Pasteur, 75015, Paris, France
- Innate Immunity Unit, Department of Immunology, Institut Pasteur, 75015, Paris, France
| | - James P Di Santo
- INSERM U1223, Institut Pasteur, 75015, Paris, France
- Innate Immunity Unit, Department of Immunology, Institut Pasteur, 75015, Paris, France
| | - Hugo Mouquet
- Humoral Immunology Laboratory, Department of Immunology, Institut Pasteur, 75015, Paris, France
- INSERM U1222, Institut Pasteur, 75015, Paris, France
| | - Olivier Schwartz
- Virus and Immunity Unit, Department of Virology, Institut Pasteur, 75015, Paris, France
| | - Mohammed Zarhrate
- Genomics Core Facility, Institut Imagine-Structure Fédérative de Recherche Necker, INSERM U1163 et INSERM US24/CNRS UMS3633, Paris Descartes Sorbonne Paris Cite University, Paris, France
| | - Mélanie Parisot
- Genomics Core Facility, Institut Imagine-Structure Fédérative de Recherche Necker, INSERM U1163 et INSERM US24/CNRS UMS3633, Paris Descartes Sorbonne Paris Cite University, Paris, France
| | - Christine Bole-Feysot
- Genomics Core Facility, Institut Imagine-Structure Fédérative de Recherche Necker, INSERM U1163 et INSERM US24/CNRS UMS3633, Paris Descartes Sorbonne Paris Cite University, Paris, France
| | - Cécile Masson
- Bioinformatics Platform, Structure Fédérative de Recherche Necker, INSERM UMR1163, Université de Paris, Imagine Institute, Paris, France
| | - Nicolas Cagnard
- Bioinformatics Platform, Structure Fédérative de Recherche Necker, INSERM UMR1163, Université de Paris, Imagine Institute, Paris, France
| | - Aurélien Corneau
- Sorbonne Université, UMS037, PASS, Plateforme de Cytométrie de la Pitié-Salpêtrière CyPS, 75013 Paris, France
| | - Camille Brunaud
- Université de Paris, Imagine Institute Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 75015 Paris, France
| | - Shen-Ying Zhang
- Université de Paris, Imagine Institute, Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM, 75015 Paris, France
- St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA
| | - Jean-Laurent Casanova
- Université de Paris, Imagine Institute, Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM, 75015 Paris, France
- St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA
- Department of Paediatric Immuno-Haematology and Rheumatology, Reference Center for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), Hôpital Necker-Enfants Malades, Assistance Publique - Hôpitaux de Paris (AP-HP), 75015 Paris, France
| | - Brigitte Bader-Meunier
- Department of Paediatric Immuno-Haematology and Rheumatology, Reference Center for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), Hôpital Necker-Enfants Malades, Assistance Publique - Hôpitaux de Paris (AP-HP), 75015 Paris, France
| | - Julien Haroche
- Department of Immunology and Infectious Disease (CIMI-Paris), Pitié-Salpêtrière University Hospital, Sorbonne Université, AP-HP, 75013 Paris, France
| | - Isabelle Melki
- Department of Paediatric Immuno-Haematology and Rheumatology, Reference Center for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), Hôpital Necker-Enfants Malades, Assistance Publique - Hôpitaux de Paris (AP-HP), 75015 Paris, France
- Department of Pediatrics, Robert-Debré University Hospital, AP-HP, Université de Paris, Paris, France
| | - Mathie Lorrot
- Department of Pediatrics, Armand-Trousseau University Hospital, AP-HP, 75012 Paris, France
| | - Mehdi Oualha
- Pediatric Intensive Care Unit, Necker-Enfants Malades University Hospital, AP-HP, Université de Paris, 75015 Paris, France
| | - Florence Moulin
- Pediatric Intensive Care Unit, Necker-Enfants Malades University Hospital, AP-HP, Université de Paris, 75015 Paris, France
| | | | | | - Marianne Leruez
- Virology Laboratory, Necker-Enfants Malades University Hospital, AP-HP, Université de Paris, 75015 Paris, France
| | - Slimane Allali
- Department of General Paediatrics and Paediatric Infectious Diseases, Necker-Enfants Malades University Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Université de Paris, 75015 Paris, France
| | - Christèle Gras-Leguen
- Pediatric Department, Nantes University Hospital, CIC 1413, INSERM, 44000 Nantes, France
| | - Loïc de Pontual
- Department of Pediatrics, Jean Verdier Hospital, Assistance Publique-Hôpitaux de Paris, Paris 13 University, Bondy, France
| | - Alain Fischer
- Department of Paediatric Immuno-Haematology and Rheumatology, Reference Center for Rheumatic, AutoImmune and Systemic Diseases in Children (RAISE), Hôpital Necker-Enfants Malades, Assistance Publique - Hôpitaux de Paris (AP-HP), 75015 Paris, France
- Université de Paris, Imagine Institute, INSERM UMR 1163, 75015 Paris, France
- Collège de France, Paris, France
| | - Darragh Duffy
- Translational Immunology Lab, Department of Immunology, Institut Pasteur, 75015 Paris, France
- Cytometry and Biomarkers UTechS, CRT, Institut Pasteur, 75015, Paris, France
| | - Fredéric Rieux-Laucat
- Université de Paris, Imagine Institute Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, INSERM UMR 1163, 75015 Paris, France
| | - Julie Toubiana
- Department of General Paediatrics and Paediatric Infectious Diseases, Necker-Enfants Malades University Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), Université de Paris, 75015 Paris, France
- Institut Pasteur, Biodiversity and Epidemiology of Bacterial Pathogens, Paris, France
| | - Mickaël M Ménager
- Université de Paris, Imagine Institute, Laboratory of Inflammatory Responses and Transcriptomic Networks in Diseases, Atip-Avenir Team, INSERM UMR 1163, 75015 Paris, France
- Labtech Single-Cell@Imagine, Imagine Institute, INSERM UMR 1163, 75015 Paris, France
| |
Collapse
|
13
|
Oualha M, Wiedemann A, Levy M, Vanel N, Moulin F, De Saint Blanquat L, Chomton M, Renolleau S, Guilbert AS, Javouhey E. Le SARS-CoV-2 en réanimation pédiatrique. Méd Intensive Réa 2021. [DOI: 10.37051/mir-00063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
Dans une moindre mesure que les réanimations adultes, les réanimations pédiatriques ont dû faire face à la pandémie du SARS-CoV-2. Les pédiatres réanimateurs ont été confrontés (i) à la prise en charge d’enfants atteints d’une primo-infection grave puis dans un 2ème temps à ceux présentant des atteintes inflammatoires systémiques post infectieuses et (ii) tandis que d’autres ont été sollicités pour aider à la prise en charge d’adulte atteints d’une forme sévère de SARS-CoV-2. Ils ont ainsi dû faire preuve d’adaptation en un temps record. Nous rapportons dans cette mise au point (i) les données de la littérature de ces deux formes sévères pédiatriques, la primo infection et les manifestations inflammatoires systémiques liées au SARS-CoV-2 ; (ii) l’expérience d’un service de réanimation pédiatrique à la prise en charge d’adultes atteints du SARS-CoV-2 et (iii) et l’impact de la pandémie sur la place des familles des enfants en situation critique dans les services de réanimation pédiatrique.
Collapse
|
14
|
de Marcellus C, Dupic L, Roux CJ, El Aouane El Ghomari I, Parize P, Luscan R, Moulin F, Kossorotoff M. Case Report: Cerebrovascular Events Associated With Bacterial and SARS-CoV-2 Infections in an Adolescent. Front Neurol 2021; 12:606617. [PMID: 33897582 PMCID: PMC8060448 DOI: 10.3389/fneur.2021.606617] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2020] [Accepted: 03/12/2021] [Indexed: 01/19/2023] Open
Abstract
Neurologic manifestations associated with Covid-19 are increasingly reported, especially stroke and acute cerebrovascular events. Beyond cardiovascular risk factors associated with age, some young adults without medical or cardiovascular history had stroke as a presenting feature of Covid-19. Suggested stroke mechanisms in this setting are inflammatory storm, subsequent hypercoagulability, and vasculitis. To date, a handful of pediatric stroke cases associated with Covid-19 have been reported, either with a cardioembolic mechanism or a focal cerebral arteriopathy. We report the case of an adolescent who presented with febrile meningism and stupor. Clinical, biological, and radiological features favored the diagnosis of Lemierre syndrome (LS), with Fusobacterium necrophorum infection (sphenoid sinusitis and meningitis) and intracranial vasculitis. The patient had concurrent SARS-CoV-2 infection. Despite medical and surgical antimicrobial treatment, stroke prevention, and venous thrombosis prevention, he presented with severe cerebrovascular complications. Venous thrombosis and stroke were observed, with an extension of intracranial vasculitis, and lead to death. As both F. necrophorum and SARS-CoV-2 enhance inflammation, coagulation, and activate endothelial cells, we discuss how this coinfection may have potentiated and aggravated the usual course of LS. The potentiation by SARS-CoV-2 of vascular and thrombotic effects of a bacterial infection may represent an underreported cerebrovascular injury mechanism in Covid-19 patients. These findings emphasize the variety of mechanisms underlying stroke in this disease. Moreover, in the setting of SARS-CoV-2 pandemic, we discuss in what extent sanitary measures, namely, lockdown and fear to attend medical facilities, may have delayed diagnosis and influenced outcomes. This case also emphasizes the role of clinical assessment and the limits of telemedicine for acute neurological condition diagnosis.
Collapse
Affiliation(s)
- Charles de Marcellus
- Pediatric Intensive Care Unit, APHP University Hospital Necker-Enfants Malades, Paris, France.,Université de Paris, Paris, France
| | - Laurent Dupic
- Pediatric Intensive Care Unit, APHP University Hospital Necker-Enfants Malades, Paris, France.,Université de Paris, Paris, France
| | - Charles-Joris Roux
- Pediatric Radiology Department, APHP University Hospital Necker-Enfants Malades, Paris, France
| | | | - Perrine Parize
- Department of Infectious Diseases and Tropical Medicine, APHP University Hospital Necker-Enfants Malades, Paris, France
| | - Romain Luscan
- Université de Paris, Paris, France.,Pediatric Otorhinolaryngology Department, APHP University Hospital Necker-Enfants Malades, Paris, France
| | - Florence Moulin
- Pediatric Intensive Care Unit, APHP University Hospital Necker-Enfants Malades, Paris, France.,Université de Paris, Paris, France
| | - Manoelle Kossorotoff
- French Center for Pediatric Stroke, Pediatric Neurology Department, APHP University Hospital Necker-Enfants Malades, Paris, France.,Inserm U1266, Paris, France
| |
Collapse
|
15
|
Bellon N, Hadj-Rabia S, Moulin F, Lambe C, Lezmi G, Charbit-Henrion F, Alby C, Le Saché-de Peufeilhoux L, Leclerc-Mercier S, Hadchouel A, Steffann J, Hovnanian A, Lapillonne A, Bodemer C. The challenging management of a series of 43 infants with Netherton syndrome: unexpected complications and novel mutations. Br J Dermatol 2020; 184:532-537. [PMID: 32479644 DOI: 10.1111/bjd.19265] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/27/2020] [Indexed: 11/28/2022]
Abstract
BACKGROUND Netherton syndrome (NS) is a rare disease caused by SPINK5 mutations, featuring variable skin and hair involvement and, in many cases, allergic manifestations with a risk of lethality, particularly in infants. The clinical management of NS is challenging. OBJECTIVES To analyse the clinical manifestations of a cohort of infants with NS managed in a reference centre and to draw up recommendations for management. METHODS We conducted a monocentric analysis of patients with NS. The inclusion criteria were management in our reference centre, a histologically or molecularly confirmed diagnosis of NS and available epidemiological, clinical and laboratory data. RESULTS A total of 43 patients with NS were included. Hypernatraemia was reported in 23 cases (54%) and associated with a greater likelihood of enteral and/or parenteral nutritional support (P < 0.001). Moreover, hypernatraemia was more frequent in patients with skin manifestations at birth (P = 0.026) and in patients bearing the c.153delT mutation in SPINK5 exon 3 (P = 0.014). The need for enteral and/or parenteral nutritional support was associated with a history of hypernatraemic dehydration (P < 0.001). Several unexpected extracutaneous complications were recorded, and new mutations were reported. The death rate (9% overall) was higher among the subset of patients bearing the c.153delT deletion. CONCLUSIONS Our data emphasize that neonatal NS is a severe and sometimes lethal multisystem disorder. Patients have a high risk of variable metabolic anomalies (i.e. lethal hypernatraemia) and therefore have major nutritional needs. Cases of NS associated with c.153delT are particularly severe. Unexpected clinical manifestations broadened the phenotypic spectrum of NS. We provide recommendations on the management of the life-threatening manifestations of NS in neonates based on our multidisciplinary experience.
Collapse
Affiliation(s)
- N Bellon
- Department of Dermatology, Reference Centre for Genodermatoses and Rare Skin Diseases (MAGEC), Necker-Enfants Malades Hospital (AP-HP), Imagine Institute, Paris, France
| | - S Hadj-Rabia
- Department of Dermatology, Reference Centre for Genodermatoses and Rare Skin Diseases (MAGEC), Necker-Enfants Malades Hospital (AP-HP), Imagine Institute, Paris, France.,Paris-Centre University, Paris, France
| | - F Moulin
- Department of Paediatric Intensive Care, Necker-Enfants Malades Hospital (AP-HP), Paris, France
| | - C Lambe
- Department of Paediatric Gastroenterology, Hepatology and Nutrition, Necker-Enfants Malades Hospital (AP-HP), Paris, France
| | - G Lezmi
- Paris-Centre University, Paris, France.,Department of Pneumo-Allergology, Necker-Enfants Malades Hospital (AP-HP), Paris, France
| | - F Charbit-Henrion
- Paris-Centre University, Paris, France.,Department of Genetics, Necker-Enfants Malades Hospital (AP-HP), Paris, France
| | - C Alby
- Department of Genetics, Necker-Enfants Malades Hospital (AP-HP), Paris, France
| | - L Le Saché-de Peufeilhoux
- Department of Dermatology, Reference Centre for Genodermatoses and Rare Skin Diseases (MAGEC), Necker-Enfants Malades Hospital (AP-HP), Imagine Institute, Paris, France
| | - S Leclerc-Mercier
- Department of Pathology, Necker-Enfants Malades Hospital (AP-HP), Paris, France
| | - A Hadchouel
- Paris-Centre University, Paris, France.,Department of Pneumo-Allergology, Necker-Enfants Malades Hospital (AP-HP), Paris, France
| | - J Steffann
- Paris-Centre University, Paris, France.,Department of Genetics, Necker-Enfants Malades Hospital (AP-HP), Paris, France
| | - A Hovnanian
- Paris-Centre University, Paris, France.,Department of Genetics, Necker-Enfants Malades Hospital (AP-HP), Paris, France.,INSERM UMR 1163, Laboratory of Genetic Skin Diseases, Imagine Institute, Paris, France
| | - A Lapillonne
- Paris-Centre University, Paris, France.,Department of Neonatology, Necker-Enfants Malades Hospital (AP-HP), Paris, France
| | - C Bodemer
- Department of Dermatology, Reference Centre for Genodermatoses and Rare Skin Diseases (MAGEC), Necker-Enfants Malades Hospital (AP-HP), Imagine Institute, Paris, France.,Paris-Centre University, Paris, France
| |
Collapse
|
16
|
Chosidow A, Benaboud S, Beranger A, Zheng Y, Moulin F, Dupic L, Renolleau S, Treluyer JM, Oualha M. Are β-lactam concentrations adequate in severe sepsis and septic shock in children? Therapie 2020; 75:633-640. [PMID: 32593420 DOI: 10.1016/j.therap.2020.04.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2019] [Revised: 12/18/2019] [Accepted: 04/02/2020] [Indexed: 01/16/2023]
Abstract
AIM OF THE STUDY Early administration of appropriate antibiotic therapy with adequate concentration is the cornerstone of the severe sepsis and septic shock's treatment. We aim to describe the plasma concentration of the most used β-lactams in critically ill children, to describe the rate of patients with suboptimal exposure, and associated clinical and biological factors. METHODS From January 2016 to May 2017, children less than 18 years old with severe sepsis or septic shock were included. Samples were collected in pediatric intensive care unit for children with severe sepsis or septic shock. β-lactam plasma concentrations were analysed using high performance liquid chromatography. RESULTS Among the 37 enrolled patients, 24 (64.9%) had insufficient concentration [cefotaxime 7/14 (43%); piperacillin-tazobactam, 10/13 (77%); amoxicillin 6/7 (86%); meropenem 3/6 (50%), cefazolin 1/4 (25%), imipenem 0/2 (0%); ceftazidime 0/1 (0%)]. Insufficient concentrations were associated with early measurements [<72hours from the sepsis' onset (P=0.035) and an increased creatinine clearance (P=0.01)]. CONCLUSION β-lactams current dosing in critically ill septic children could be suboptimal.
Collapse
Affiliation(s)
- Anais Chosidow
- Armand-Trousseau hospital, AP-HP, pediatric department, 26, avenue du Dr-Arnold-Netter, 75012 Paris, France.
| | - Sihem Benaboud
- Pharmacology department, Cochin hospital, 75014 Paris, France
| | - Agathe Beranger
- Pediatric intensive care unit, Necker hospital, 75015 Paris, France
| | - Yi Zheng
- Pharmacology department, Cochin hospital, 75014 Paris, France
| | - Florence Moulin
- Pediatric intensive care unit, Necker hospital, 75015 Paris, France
| | - Laurent Dupic
- Pediatric intensive care unit, Necker hospital, 75015 Paris, France
| | | | - Jean-Marc Treluyer
- Pharmacology department, Cochin hospital, 75014 Paris, France; Pediatric intensive care unit, Necker hospital, 75015 Paris, France
| | - Mehdi Oualha
- Pediatric intensive care unit, Necker hospital, 75015 Paris, France
| |
Collapse
|
17
|
Heilbronner C, Berteloot L, Tremolieres P, Dupic L, de Saint Blanquat L, Lesage F, Odièvre MH, de Marcellus C, Fourgeaud J, de Montalembert M, Grimaud M, Moulin F, Renolleau S, Allali S, Oualha M. Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit. Br J Haematol 2020; 190:e21-e24. [PMID: 32420608 PMCID: PMC7276717 DOI: 10.1111/bjh.16802] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2020] [Accepted: 05/07/2020] [Indexed: 11/29/2022]
Affiliation(s)
- Claire Heilbronner
- Réanimation et Soins Continus Medico-chirurgicaux, Hôpital Necker-Enfants Malades, APHP Paris, Paris, France
| | - Laureline Berteloot
- Service d'imagerie médicale pédiatrique, Hôpital Necker Enfants Malades, APHP Paris, Paris, France
| | - Pierre Tremolieres
- Unité d'hémaphérèse thérapeutique, Hôpital Necker-Enfants Malades, APHP Paris, Paris, France
| | - Laurent Dupic
- Réanimation et Soins Continus Medico-chirurgicaux, Hôpital Necker-Enfants Malades, APHP Paris, Paris, France
| | - Laure de Saint Blanquat
- Réanimation et Soins Continus Medico-chirurgicaux, Hôpital Necker-Enfants Malades, APHP Paris, Paris, France
| | - Fabrice Lesage
- Réanimation et Soins Continus Medico-chirurgicaux, Hôpital Necker-Enfants Malades, APHP Paris, Paris, France
| | - Marie-Hélène Odièvre
- Pédiatrie générale, Centre de la drépanocytose, Hôpital Armand Trousseau, APHP, Université Paris, Paris, Sorbonne, France
| | - Charles de Marcellus
- Réanimation et Soins Continus Medico-chirurgicaux, Hôpital Necker-Enfants Malades, APHP Paris, Paris, France
| | - Jacques Fourgeaud
- Laboratoire de Virologie, Hôpital Necker-Enfants Malades, Paris University, APHP Paris, Paris, France
| | - Marianne de Montalembert
- Pédiatrie générale et maladies infectieuses, Centre de référence de la drépanocytose, Hôpital Necker-Enfants Malades, APHP Paris, Paris, France
| | - Marion Grimaud
- Réanimation et Soins Continus Medico-chirurgicaux, Hôpital Necker-Enfants Malades, APHP Paris, Paris, France
| | - Florence Moulin
- Réanimation et Soins Continus Medico-chirurgicaux, Hôpital Necker-Enfants Malades, APHP Paris, Paris, France
| | - Sylvain Renolleau
- Réanimation et Soins Continus Medico-chirurgicaux, Hôpital Necker-Enfants Malades, APHP Paris, Paris, France
| | - Slimane Allali
- Pédiatrie générale et maladies infectieuses, Centre de référence de la drépanocytose, Hôpital Necker-Enfants Malades, APHP Paris, Paris, France
| | - Mehdi Oualha
- Réanimation et Soins Continus Medico-chirurgicaux, Hôpital Necker-Enfants Malades, APHP Paris, Paris, France
| |
Collapse
|
18
|
Oualha M, Bendavid M, Berteloot L, Corsia A, Lesage F, Vedrenne M, Salvador E, Grimaud M, Chareyre J, de Marcellus C, Dupic L, de Saint Blanquat L, Heilbronner C, Drummond D, Castelle M, Berthaud R, Angoulvant F, Toubiana J, Pinhas Y, Frange P, Chéron G, Fourgeaud J, Moulin F, Renolleau S. Severe and fatal forms of COVID-19 in children. Arch Pediatr 2020; 27:235-238. [PMID: 32518045 PMCID: PMC7269941 DOI: 10.1016/j.arcped.2020.05.010] [Citation(s) in RCA: 93] [Impact Index Per Article: 23.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2020] [Accepted: 05/28/2020] [Indexed: 12/11/2022]
Abstract
Objectives The aim of this study was to describe severe forms of novel coronavirus disease 2019 in children, including patient characteristics, clinical, laboratory, and imaging findings, as well as the disease management and outcomes. Methods This was a retrospective, single-center, observational study conducted in a pediatric intensive and high-dependency care unit (PICU, HDU) in an urban hospital in Paris. All patients, aged from 1 month to 18 years, admitted for confirmed or highly suspected SARS-CoV-2 were included. Results We analyzed the data of 27 children. Comorbidities (n = 19, 70%) were mainly neurological (n = 7), respiratory, (n = 4), or sickle cell disease (n = 4). SARS-CoV-2 PCR results were positive in 24 children (nasopharyngeal swabs). The three remaining children had a chest CT scan consistent with COVID-19. Respiratory involvement was observed in 24 patients (89%). Supportive treatments were invasive mechanical ventilation (n = 9), catecholamine (n = 4), erythropheresis (n = 4), renal replacement therapy (n = 1), and extracorporeal membrane oxygenation (n = 1). Five children died, of whom three were without past medical history. Conclusion This study highlighted the large spectrum of clinical presentation and time course of disease progression as well as the non-negligible occurrence of pediatric life-threatening and fatal cases of COVID-19 mostly in patients with comorbidities. Additional laboratory investigations are needed to further analyze the mechanism underlying the variability of SARS-Cov-2 pathogenicity in children.
Collapse
Affiliation(s)
- M Oualha
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France.
| | - M Bendavid
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - L Berteloot
- Pediatric Radiology Department, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France; INSERM U1163, Université Paris Descartes-Sorbonne Paris Cité, Institut Imagine, France
| | - A Corsia
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - F Lesage
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - M Vedrenne
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - E Salvador
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - M Grimaud
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - J Chareyre
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - C de Marcellus
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - L Dupic
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - L de Saint Blanquat
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - C Heilbronner
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - D Drummond
- Department of pediatric pneumology and allergology, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France; INSERM UMR 1138, Université de Paris, Paris, France
| | - M Castelle
- Department of pediatric Immuno-hematology and rhumatology, Necker-Enfants Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - R Berthaud
- Department of Pediatric Nephrology, Necker-Enfants Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - F Angoulvant
- Pediatric Emergency Department, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France; INSERM, Centre de Recherche des Cordeliers, UMRS 1138, Université de Paris, Paris, France
| | - J Toubiana
- Department of General Paediatrics and Paediatric Infectious Diseases, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - Y Pinhas
- Department of General Paediatrics and Paediatric Infectious Diseases, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - P Frange
- Clinical microbiology laboratory, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France; EHU 7328 PACT, Imagine institute, Université de Paris, Paris, France
| | - G Chéron
- Pediatric Emergency Department, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - J Fourgeaud
- Virology laboratory, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, EHU 7328 PACT, Imagine Institute, University of Paris, Paris, France
| | - F Moulin
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| | - S Renolleau
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, APHP, Centre-Université de Paris, Paris, France
| |
Collapse
|
19
|
Grimaud M, Starck J, Levy M, Marais C, Chareyre J, Khraiche D, Leruez-Ville M, Quartier P, Léger PL, Geslain G, Semaan N, Moulin F, Bendavid M, Jean S, Poncelet G, Renolleau S, Oualha M. Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children. Ann Intensive Care 2020; 10:69. [PMID: 32488505 PMCID: PMC7266128 DOI: 10.1186/s13613-020-00690-8] [Citation(s) in RCA: 198] [Impact Index Per Article: 49.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2020] [Accepted: 05/25/2020] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND A recent increase in children admitted with hypotensive shock and fever in the context of the COVID-19 outbreak requires an urgent characterization and assessment of the involvement of SARS-CoV-2 infection. This is a case series performed at 4 academic tertiary care centers in Paris of all the children admitted to the pediatric intensive care unit (PICU) with shock, fever and suspected SARS-CoV-2 infection between April 15th and April 27th, 2020. RESULTS 20 critically ill children admitted for shock had an acute myocarditis (left ventricular ejection fraction, 35% (25-55); troponin, 269 ng/mL (31-4607)), and arterial hypotension with mainly vasoplegic clinical presentation. The first symptoms before PICU admission were intense abdominal pain and fever for 6 days (1-10). All children had highly elevated C-reactive protein (> 94 mg/L) and procalcitonin (> 1.6 ng/mL) without microbial cause. At least one feature of Kawasaki disease was found in all children (fever, n = 20, skin rash, n = 10; conjunctivitis, n = 6; cheilitis, n = 5; adenitis, n = 2), but none had the typical form. SARS-CoV-2 PCR and serology were positive for 10 and 15 children, respectively. One child had both negative SARS-CoV-2 PCR and serology, but had a typical SARS-CoV-2 chest tomography scan. All children but one needed an inotropic/vasoactive drug support (epinephrine, n = 12; milrinone, n = 10; dobutamine, n = 6, norepinephrine, n = 4) and 8 were intubated. All children received intravenous immunoglobulin (2 g per kilogram) with adjuvant corticosteroids (n = 2), IL 1 receptor antagonist (n = 1) or a monoclonal antibody against IL-6 receptor (n = 1). All children survived and were afebrile with a full left ventricular function recovery at PICU discharge. CONCLUSIONS Acute myocarditis with intense systemic inflammation and atypical Kawasaki disease is an emerging severe pediatric disease following SARS-CoV-2 infection. Early recognition of this disease is needed and referral to an expert center is recommended. A delayed and inappropriate host immunological response is suspected. While underlying mechanisms remain unclear, further investigations are required to target an optimal treatment.
Collapse
Affiliation(s)
- Marion Grimaud
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Julie Starck
- Pediatric and Neonatal Intensive Care Unit, Armand-Trousseau University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Michael Levy
- Pediatric Intensive Care Unit, Robert Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France
| | - Clémence Marais
- Pediatric and Neonatal Intensive Care Unit, Kremlin-Bicêtre University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Judith Chareyre
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Diala Khraiche
- M3C-Necker, Congenital and Pediatric Cardiology, Necker-Enfants-Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | | | - Pierre Quartier
- Paediatric Hematology-Immunology and Rheumatology Unit, Reference center for Rheumatic, AutoImmune and Systemic diseases in children (RAISE), Necker-Enfants Malades University Hospital, Assistance Publique-Hôpitaux de Paris, IMAGINE Institute, Université de Paris, Paris, France
| | - Pierre Louis Léger
- Pediatric and Neonatal Intensive Care unit, Armand-Trousseau University Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne University, Paris, France
| | - Guillaume Geslain
- Pediatric Intensive Care Unit, Robert Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France
| | - Nada Semaan
- Pediatric and Neonatal Intensive Care Unit, Kremlin-Bicêtre University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Florence Moulin
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Matthieu Bendavid
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Sandrine Jean
- Pediatric and Neonatal Intensive Care Unit, Armand-Trousseau University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Géraldine Poncelet
- Pediatric Intensive Care Unit, Robert Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France
| | - Sylvain Renolleau
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris University, EA7323, 75006, Paris, France
| | - Mehdi Oualha
- Pediatric Intensive Care Unit, Necker-Enfants-Malades University Hospital, Assistance Publique-Hôpitaux de Paris, Paris University, EA7323, 75006, Paris, France.
| |
Collapse
|
20
|
Aubart M, Gitiaux C, Roux CJ, Levy R, Schuffenecker I, Mirand A, Bach N, Moulin F, Bergounioux J, Leruez-Ville M, Rozenberg F, Sterlin D, Musset L, Antona D, Boddaert N, Zhang SY, Kossorotoff M, Desguerre I. Severe Acute Flaccid Myelitis Associated With Enterovirus in Children: Two Phenotypes for Two Evolution Profiles? Front Neurol 2020; 11:343. [PMID: 32411086 PMCID: PMC7198806 DOI: 10.3389/fneur.2020.00343] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2020] [Accepted: 04/07/2020] [Indexed: 12/19/2022] Open
Abstract
Acute flaccid myelitis (AFM) is an acute paralysis syndrome defined by a specific inflammation of the anterior horn cells of the spinal cord. From 2014, worrying waves of life-threatening AFM consecutive to enterovirus infection (EV-D68 and EV-A71) have been reported. We describe 10 children displaying an AFM with an EV infection, the treatments performed and the 1 to 3-years follow-up. Two groups of patients were distinguished: 6 children (“polio-like group”) had severe motor disability whereas 4 other children (“brainstem group”) displayed severe brainstem weakness requiring ventilation support. Electrodiagnostic studies (n = 8) support the presence of a motor neuronopathy associated to myelitis. The best prognosis factor seems to be the motor recovery after the first 4 weeks of the disease.
Collapse
Affiliation(s)
- Melodie Aubart
- Department of Paediatric Neurology, Necker-Enfants malades Hospital, University of Paris, AP-HP, Paris, France.,INSERM 1163, Imagine Institute, Paris, France
| | - Cyril Gitiaux
- Department of Paediatric Neurophysiology, Necker-Enfants malades Hospital, University of Paris, AP-HP, Paris, France.,INSERM U955-Team 10, Department of Neurosciences, Mondor Biomedical Research Institute, Paris-Est University, Créteil, France
| | - Charles Joris Roux
- Department of Paediatric Radiology, Necker-Enfants malades Hospital, University of Paris, AP-HP, Paris, France
| | - Raphael Levy
- Department of Paediatric Radiology, Necker-Enfants malades Hospital, University of Paris, AP-HP, Paris, France
| | - Isabelle Schuffenecker
- Laboratory of Virology, National Reference Center for Enterovirus, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France
| | - Audrey Mirand
- Laboratory of Virology, National Reference Center for Enterovirus Associated Laboratory, CHU Clermont-Ferrand, Clermont-Ferrand, France
| | - Nathalie Bach
- Paediatric Department, CHU Caen-Normandie, Caen, France
| | - Florence Moulin
- Intensive Care Unit, Necker-Enfants malades Hospital, University of Paris, AP-HP, Paris, France
| | - Jean Bergounioux
- Intensive Care Unit, CHU Raymond Poincaré, Paris Saclay University, AP-HP, Garches, France
| | - Marianne Leruez-Ville
- Laboratory of Virology, Necker-Enfants malades Hospital, University of Paris, AP-HP, Paris, France
| | - Flore Rozenberg
- Laboratory of Virology, Cochin Hospital, University of Paris, AP-HP, Paris, France
| | - Delphine Sterlin
- Laboratory of Immunology, Pitié-Salpétrière Hospital, Sorbonne University, AP-HP, Paris, France
| | - Lucile Musset
- Laboratory of Immunology, Pitié-Salpétrière Hospital, Sorbonne University, AP-HP, Paris, France
| | - Denise Antona
- Direction des maladies infectieuses, Santé publique France, Saint-Maurice, France
| | - Nathalie Boddaert
- INSERM U955-Team 10, Department of Neurosciences, Mondor Biomedical Research Institute, Paris-Est University, Créteil, France.,Department of Paediatric Radiology, Necker-Enfants malades Hospital, University of Paris, AP-HP, Paris, France
| | | | - Manoelle Kossorotoff
- Department of Paediatric Neurology, Necker-Enfants malades Hospital, University of Paris, AP-HP, Paris, France
| | - Isabelle Desguerre
- Department of Paediatric Neurology, Necker-Enfants malades Hospital, University of Paris, AP-HP, Paris, France
| |
Collapse
|
21
|
Salvador E, Oualha M, Bille E, Beranger A, Moulin F, Benaboud S, Boujaafar S, Gana I, Urien S, Zheng Y, Toubiana J, Briand C, Bustarret O, Geslain G, Renolleau S, Treluyer JM, Hirt D. Population pharmacokinetics of cefazolin in critically ill children infected with methicillin-sensitive Staphylococcus aureus. Clin Microbiol Infect 2020; 27:413-419. [PMID: 32360445 DOI: 10.1016/j.cmi.2020.04.022] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2020] [Revised: 03/27/2020] [Accepted: 04/21/2020] [Indexed: 11/26/2022]
Abstract
OBJECTIVES Cefazolin is one of curative treatments for infections due to methicillin-sensitive Staphylococcus aureus (MSSA). Both growth and critical illness may impact the pharmacokinetic (PK) parameters. We aimed to build a population PK model for cefazolin in critically ill children in order to optimize individual dosing regimens. METHODS We included all children (age < 18 years, body weight (BW) > 2.5 kg) receiving cefazolin for MSSA infection. Cefazolin total plasma concentrations were quantified by high-performance liquid chromatography. A data modelling process was performed with the software MONOLIX. Monte Carlo simulations were used in order to attain the PK target of 100% fT > 4 ×MIC. RESULTS Thirty-nine patients with a median (range) age of 7 (0.1-17) years and a BW of 21 (2.8-79) kg were included. The PK was ascribed to a one-compartment model, where typical clearance and volume of distribution estimations were 1.4 L/h and 3.3 L respectively. BW, according to the allometric rules, and estimated glomerular filtration rate (eGFR) on clearance were the two influential covariates. Continuous infusion with a dosing of 100 mg/kg/day to increase to 150 mg/kg/day for children with a BW < 10 kg or eGFR >200 mL/min/1.73m2 were the best schemes to reach the PK target of 100% fT> 4 ×MIC. CONCLUSIONS In critically ill children infected with MSSA, continuous infusion seems to be the most appropriate scheme to reach the PK target of 100 % fT > 4 ×MIC in children with normal and augmented renal function.
Collapse
Affiliation(s)
- E Salvador
- Department of Paediatric Intensive Care Unit, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France; Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France.
| | - M Oualha
- Department of Paediatric Intensive Care Unit, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France; Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France
| | - E Bille
- Microbiological Laboratory, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France
| | - A Beranger
- Department of Paediatric Intensive Care Unit, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France; Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France
| | - F Moulin
- Microbiological Laboratory, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France
| | - S Benaboud
- Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France; Department of Clinical Pharmacology, Cochin Hospital, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France
| | - S Boujaafar
- Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France; Department of Clinical Pharmacology, Cochin Hospital, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France
| | - I Gana
- Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France; Department of Clinical Pharmacology, Cochin Hospital, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France
| | - S Urien
- Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France
| | - Y Zheng
- Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France; Department of Clinical Pharmacology, Cochin Hospital, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France
| | - J Toubiana
- Department of General Paediatrics and Paediatric Infectious Diseases, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France
| | - C Briand
- Department of Paediatric Immunohaematology, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France
| | - O Bustarret
- Department of Surgical Paediatric Intensive Care Unit, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France
| | - G Geslain
- Department of Surgical Paediatric Intensive Care Unit, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France
| | - S Renolleau
- Department of Paediatric Intensive Care Unit, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France
| | - J-M Treluyer
- Department of Paediatric Intensive Care Unit, Necker Enfants Malades Hospital, Paris Descartes University, Sorbonne-Paris Cité, 149 Rue de Sèvres, 75015, Paris, France; Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France; Department of Clinical Pharmacology, Cochin Hospital, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France
| | - D Hirt
- Pharmacology and Drug Evaluation in Children and Pregnant Women EA7323, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France; Department of Clinical Pharmacology, Cochin Hospital, Paris Descartes University, 27 Rue Du Faubourg Saint Jacques, 75014, Paris, France
| |
Collapse
|
22
|
Tuchmann-Durand C, Thevenet E, Moulin F, Lesage F, Bouchereau J, Oualha M, Khraiche D, Brassier A, Wicker C, Gobin-Limballe S, Arnoux JB, Lacaille F, Wicart C, Coat B, Schlattler J, Cisternino S, Renolleau S, Secretan PH, De Lonlay P. Administration of gamma-hydroxybutyrate instead of beta-hydroxybutyrate to a liver transplant recipient suffering from propionic acidemia and cardiomyopathy: A case report on a medication prescribing error. JIMD Rep 2020; 51:25-29. [PMID: 32071836 PMCID: PMC7012734 DOI: 10.1002/jmd2.12090] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/02/2019] [Revised: 11/22/2019] [Accepted: 11/26/2019] [Indexed: 12/12/2022] Open
Abstract
Beta‐hydroxybutyrate (BHB) is a synthetic ketone body used as an adjuvant energy substrate in the treatment of patients with metabolic cardiomyopathy. A medication prescribing error led to the administration of the general anesthetic sodium gamma‐hydroxybutyrate (GHB) instead of sodium BHB in a liver transplant recipient with propionic acidemia and cardiomyopathy, causing acute coma. A 15‐year‐old boy suffering from neonatal propionic acidemia underwent liver transplantation (LT) for metabolic decompensation and cardiomyopathy (treated with cardiotropic drugs and BHB) diagnosed a year previously. The patient had been rapidly extubated after LT, and was recovering well. Eight days after LT, the patient suddenly became comatose. No metabolic, immunological, hypertensive, or infectious complications were apparent. The brain magnetic resonance imaging and electroencephalography results were normal. The coma was soon attributed to a medication prescribing error: administration of GHB instead of BHB on day 8 post‐LT. The patient recovered fully within a few hours of GHB withdrawal. The computerized prescription system had automatically suggested the referenced anesthetic GHB (administered intravenously) instead of the non‐referenced ketone body BHB, triggering coma in our patient. A computerized prescription system generated a medication prescribing error for a rare disease, in which the general anesthetic GHB was mistaken for the nonreferenced energy substrate BHB.
Collapse
Affiliation(s)
- Caroline Tuchmann-Durand
- Imagine Institut des Maladies Génétiques, Paris, France and Biotherapy Department Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris Paris France
| | - Eloise Thevenet
- Reference Center for Inherited Metabolic Diseases Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris Paris France
| | - Florence Moulin
- Intensive Care Unit Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris and Paris Descartes University Paris France
| | - Fabrice Lesage
- Intensive Care Unit Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris and Paris Descartes University Paris France
| | - Juliette Bouchereau
- Reference Center for Inherited Metabolic Diseases Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris Paris France
| | - Mehdi Oualha
- Intensive Care Unit Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris and Paris Descartes University Paris France
| | - Diala Khraiche
- Cardiology Care Unit Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris Paris France
| | - Anaïs Brassier
- Reference Center for Inherited Metabolic Diseases Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris Paris France
| | - Camille Wicker
- Reference Center for Inherited Metabolic Diseases Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris Paris France
| | - Stéphanie Gobin-Limballe
- Molecular Genetic Department Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris Paris France
| | - Jean-Baptiste Arnoux
- Reference Center for Inherited Metabolic Diseases Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris Paris France
| | - Florence Lacaille
- Paediatric Hepatology Unit, Reference Center for Rare Pediatric Liver Diseases, Department of Gastroenterology-Hepatology-Nutrition Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris, APHP, Filière Filfoie, ERN Transplantchild Paris France
| | - Clotilde Wicart
- Reference Center for Inherited Metabolic Diseases Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris Paris France
| | - Bruno Coat
- Pharmacy's Department Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris Paris France
| | - Joel Schlattler
- Pharmacy's Department Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris Paris France
| | - Salvatore Cisternino
- Pharmacy's Department Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris Paris France
| | - Sylvain Renolleau
- Intensive Care Unit Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris, Paris and Paris Descartes University Paris France
| | - Philippe-Henri Secretan
- Pharmacy's Department Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris Paris France
| | - Pascale De Lonlay
- Reference Center for Inherited Metabolic Diseases Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris Paris France.,Imagine Institut des Maladies Génétiques Filière G2M, MetabERN, INEM 1151, Paris Descartes University Paris France
| |
Collapse
|
23
|
Frange P, Toubiana J, Parize P, Moulin F, Scemla A, Leruez-Ville M. Preventing respiratory syncytial virus infections in hospitalized children and adults: should we do better? Infect Prev Pract 2020; 2:100041. [PMID: 34316555 PMCID: PMC7148660 DOI: 10.1016/j.infpip.2020.100041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2020] [Accepted: 01/30/2020] [Indexed: 11/30/2022] Open
Abstract
Objective To compare the burden of nosocomial and community-acquired respiratory syncytial virus (RSV)-associated acute lower respiratory tract infections (ALRIs) in adult and pediatric patients concomitantly admitted to a French tertiary hospital, and to evaluate the effectiveness of existing infection control measures. Patients and methods We prospectively included all adult and pediatric patients admitted to Necker hospital (Paris) between October 2018 and February 2019 with a diagnosis of RSV-associated ALRI. We compared characteristics of ALRIs between patients with community-acquired versus nosocomial infections and, in each group, between children and adults. Results Community-acquired and nosocomial RSV-associated ALRIs were diagnosed in 229 and 11 inpatients, respectively. The burden of community-acquired infections was higher in children than in adults: 2.1% versus 0.2% of the total number of pediatric and adult inpatients, respectively (p < 0.0001); 4.2% versus 0.2% of the total number of hospitalization days in pediatric and adult units, respectively (p < 0.0001). Compared to inpatients with community-acquired ALRIs, those with nosocomial infections were more frequently adults (45.5% versus 2.6%, p = 0.0005) and subjects with at least one chronic complex condition (100.0% versus 41.0%, p < 0.0001). The total number of hospitalization days due to nosocomial ALRIs was higher in adults than in children (0.32% versus 0.11%, p < 0.0001). Conclusions Nosocomial RSV-associated ALRIs rarely occurred, suggesting a good effectiveness of our infection control strategy. However, the burden of nosocomial infection was higher in adults than in children, suggesting that education and training of healthcare personnel, patients and visitors about the risk of nosocomial RSV infections should be reinforced in adult wards.
Collapse
Affiliation(s)
- Pierre Frange
- Laboratoire de Microbiologie Clinique, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Necker - Enfants Malades, Paris, France.,Institut Imagine, Université de Paris, EHU 7327, Paris, France
| | - Julie Toubiana
- Université de Paris, Service de Pédiatrie Générale et Maladies Infectieuses, AP-HP, Hôpital Necker - Enfants Malades, Paris, France.,CNR de la Coqueluche et Autres Bordetelloses, Unité « Biodiversité et épidémiologie des Bactéries Pathogènes », Institut Pasteur, Paris, France
| | - Perrine Parize
- Université Paris Descartes, Centre d'Infectiologie Necker-Pasteur, IHU Imagine, AP-HP, Hôpital Necker - Enfants Malades, Paris, France
| | - Florence Moulin
- Service de Réanimation et Surveillance Continue Médico-chirurgicale Pédiatrique, AP-HP, Hôpital Necker Enfants-Malades, Paris, France
| | - Anne Scemla
- Service de Néphrologie - Transplantation, AP-HP, Hôpital Necker-Enfants Malades, Paris, France.,RTRS Centaure, Labex Transplantex, Université de Paris, Paris, France
| | - Marianne Leruez-Ville
- Laboratoire de Microbiologie Clinique, Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Necker - Enfants Malades, Paris, France.,Institut Imagine, Université de Paris, EHU 7327, Paris, France.,CNR Cytomegalovirus, Laboratoire Associé, 149 Rue de Sèvres, 75015, Paris, France
| |
Collapse
|
24
|
Welfringer-Morin A, Moulin F, Drummond D, Oualha M, De Saint Blanquat L, Bendavid M, Aoust L, Belahda A, Kossorotoff M, Fertitta L, Bellon N, Hadj-Rabia S, Delacourt C, Leclerc-Mercier S, Frassati-Biaggi A, De Prost N, Oro S, Renolleau S, Bodemer C. Nécrolyse épidermique toxique de l’enfant : deux observations inhabituelles d’évolution fatale. Ann Dermatol Venereol 2019. [DOI: 10.1016/j.annder.2019.09.186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
25
|
Debray A, Nathanson S, Moulin F, Salomon J, Davido B. Eosinopenia as a marker of diagnosis and prognostic to distinguish bacterial from aseptic meningitis in pediatrics. Eur J Clin Microbiol Infect Dis 2019; 38:1821-1827. [PMID: 31230204 DOI: 10.1007/s10096-019-03614-y] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2019] [Accepted: 06/11/2019] [Indexed: 01/21/2023]
Abstract
Procalcitonin (PCT) has proven its efficacy to distinguish bacterial from aseptic meningitis in children. Nevertheless, its use in routine is limited by its cost and availability, especially in low- and middle-income countries. It is now acknowledged that eosinopenia is a marker of infection and/or severity of the systemic inflammatory response. Although no study ever demonstrated that eosinopenia could differentiate bacterial from viral infection, we decided to conduct a study concerning meningitis in children. This bicentric and retrospective study was conducted between January 2012 and October 2018, in children hospitalized for meningitis. The white blood cell was systematically gathered at the admission to evaluate the eosinophil count. Characteristic data were compared between 2 groups: documented bacterial meningitis (DBP) and aseptic meningitis which includes documented viral meningitis (DVM) and non-documented meningitis (ND). Among 190 patients admitted for meningitis, 151 were analyzed, including DBM (n = 45), DVM (n = 73), and ND (n = 33) meningitis. Groups were comparable. Mean age was 33 ± 48 months with a sex ratio of 1.6. Mean of eosinophil count was 15 ± 34/mm3 in the DBM group versus 132 ± 167/mm3 for the aseptic meningitis group (p < 0.0001). Best threshold for the diagnosis of bacterial meningitis was an eosinophil count < 5/mm3 with a sensitivity of 80% and specificity of 73% and a likelihood ratio of 2.9. Eosinopenia seems to be a reliable and non-invasive marker of bacterial meningitis in pediatrics. The absence of extra cost makes it very interesting in low- and middle-income countries or when usual biomarkers such as PCT are unavailable.
Collapse
Affiliation(s)
- Agathe Debray
- Service de Maladies Infectieuses et Tropicales, Groupe Hospitalier Paris Ile de France Ouest, Hôpital Universitaire Raymond-Poincaré, AP-HP, 92380, Garches, France
| | | | - Florence Moulin
- Réanimation pédiatrique, Hôpital Universitaire Necker-enfants malades, AP-HP, 75015, Paris, France
| | - Jérome Salomon
- Service de Maladies Infectieuses et Tropicales, Groupe Hospitalier Paris Ile de France Ouest, Hôpital Universitaire Raymond-Poincaré, AP-HP, 92380, Garches, France
| | - Benjamin Davido
- Service de Maladies Infectieuses et Tropicales, Groupe Hospitalier Paris Ile de France Ouest, Hôpital Universitaire Raymond-Poincaré, AP-HP, 92380, Garches, France.
| |
Collapse
|
26
|
Vidal C, Moulin F, Nassif X, Galmiche L, Borgel D, Charbit A, Picard C, Mira JP, Lortholary O, Jamet A, Toubiana J. Fulminant arterial vasculitis as an unusual complication of disseminated staphylococcal disease due to the emerging CC1 methicillin-susceptible Staphylococcus aureus clone: a case report. BMC Infect Dis 2019; 19:302. [PMID: 30943907 PMCID: PMC6446405 DOI: 10.1186/s12879-019-3933-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2018] [Accepted: 03/24/2019] [Indexed: 02/04/2023] Open
Abstract
BACKGROUND Staphylococcus aureus has emerged as a leading cause of invasive severe diseases with a high rate of morbidity and mortality worldwide. The wide spectrum of clinical manifestations and outcome observed in staphylococcal illness may be a consequence of both microbial factors and variability of the host immune response. CASE PRESENTATION A 14-years old child developed limb ischemia with gangrene following S. aureus bloodstream infection. Histopathology revealed medium-sized arterial vasculitis. The causing strain belonged to the emerging clone CC1-MSSA and numerous pathogenesis-related genes were identified. Patient's genotyping revealed functional variants associated with severe infections. A combination of virulence and host factors might explain this unique severe form of staphylococcal disease. CONCLUSION A combination of virulence and genetic host factors might explain this unique severe form of staphylococcal disease.
Collapse
Affiliation(s)
- Charles Vidal
- Department of Microbiology, Necker Enfants-malades hospital, APHP, Paris Descartes University, Paris, EU, France
| | - Florence Moulin
- Department of Pediatric Intensive Care Unit, Necker Enfants-Malades Hospital, APHP, Paris Descartes University, Paris, EU, France
| | - Xavier Nassif
- Department of Microbiology, Necker Enfants-malades hospital, APHP, Paris Descartes University, Paris, EU, France
| | - Louise Galmiche
- Pathology Department, Necker Enfants-Malades Hospital, APHP, Paris Descartes University, Paris, EU, France
| | - Delphine Borgel
- Department of Hematology, Necker Enfants-Malades Hospital, APHP, Paris Descartes University, Paris, EU, France
| | - Alain Charbit
- Necker-Enfants-Malades Institute, INSERM U1151; CNRS UMR8253, Paris, France
| | - Capucine Picard
- Center for the Study of Primary Immunodeficiencies, Necker Enfants Malades Hospital, APHP, Paris Descartes University, Paris, EU, France.,IHU Imagine, Laboratory of Human Genetics of Infectious Diseases, INSERM U1163, Paris, EU, France
| | - Jean-Paul Mira
- Medical Intensive Care Unit, Cochin Hospital, AP-HP, Paris Descartes University, Paris, EU, France.,Department of Infection, Immunity and Inflammation, Institut Cochin, INSERM U1016, Paris, EU, France
| | - Olivier Lortholary
- Department of Infectious Diseases and Tropical Medicine, Necker Enfants-Malades Hospital, Necker-Pasteur Infectious Diseases Center, Université Paris Descartes, IHU Imagine, Paris, EU, France
| | - Anne Jamet
- Department of Microbiology, Necker Enfants-malades hospital, APHP, Paris Descartes University, Paris, EU, France.,Necker-Enfants-Malades Institute, INSERM U1151; CNRS UMR8253, Paris, France
| | - Julie Toubiana
- Department of Infection, Immunity and Inflammation, Institut Cochin, INSERM U1016, Paris, EU, France. .,Department of General Pediatrics and Pediatric Infectious Diseases, Necker Enfants-Malades Hospital, APHP, Paris Descartes University, 149 rue de Sèvres, 75015, Paris, EU, France.
| |
Collapse
|
27
|
Alby-Laurent F, Lambe C, Ferroni A, Salvi N, Lebeaux D, Le Gouëz M, Castelle M, Moulin F, Nassif X, Lortholary O, Chalumeau M, Toubiana J. Salvage Strategy for Long-Term Central Venous Catheter-Associated Staphylococcus aureus Infections in Children. Front Pediatr 2018; 6:427. [PMID: 30740390 PMCID: PMC6355702 DOI: 10.3389/fped.2018.00427] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/11/2018] [Accepted: 12/21/2018] [Indexed: 11/13/2022] Open
Abstract
Introduction: Current international guidelines strongly recommend catheter removal in case of S. aureus central line-associated bloodstream infection (CLASBI), but a catheter salvage strategy may be considered in children given age-related specificities. No data is available regarding the outcome of this strategy in children. This study aims to evaluate catheter salvage strategy in children with S. aureus CLABSI, and to determine treatment failure rates and associated risk factors. Methods: We retrospectively analyzed data for all children <18 years having S. aureus CLABSI on a long-term central venous catheter in a tertiary hospital from 2010 to 2014. We defined catheter salvage strategy as a central venous catheter left in place ≥3 days after initiation of empiric treatment for suspected bacteremia, and catheter salvage strategy failure as the persistence or relapse of bacteremia with a S. aureus strain harboring the same antibiotic susceptibility pattern, or the occurrence or the worsening of local or systemic infectious complication between 72 h and 28 days after the first positive blood culture. Results: During the study period, 49 cases of S. aureus CLABSI on long-term central venous catheters were observed in 41 children (including 59% with long-term parenteral nutrition) and 6 (15%) isolates were resistant to methicillin. A catheter salvage strategy was chosen in 37/49 (76%) cases and failed in 12/37 (32%) cases. Initial presence of bloodstream co-infection, serum concentration of vancomycin under the targeted value and inadequate empiric treatment were significantly associated with catheter salvage therapy failure. Conclusions: The catheter salvage strategy of S. aureus CLABSI on a long-term central venous catheter was frequent in the studied hospital and failed only in one third of cases.
Collapse
Affiliation(s)
- Fanny Alby-Laurent
- Department of General Pediatrics and Infectious Diseases, Necker-Enfants Malades University Hospital, AP-HP, Paris Descartes University, Sorbonne Paris Cité, Paris, France
| | - Cécile Lambe
- Department of Pediatric Gastroenterology, Hepatology and Nutrition, Necker-Enfants Malades University Hospital, AP-HP, Paris Descartes University, Sorbonne Paris Cité, Paris, France
| | - Agnès Ferroni
- Department of Clinical Microbiology, Necker-Enfants Malades University Hospital, AP-HP, Paris Descartes University, Sorbonne Paris Cité, Paris, France
| | - Nadège Salvi
- Department of Pediatric Critical Care and Anesthesia, Necker-Enfants Malades University Hospital, AP-HP, Paris, France
| | - David Lebeaux
- Necker-Pasteur Center for Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, AP-HP, Paris Descartes University, Sorbonne Paris Cité, Paris, France
| | - Morgane Le Gouëz
- Department of General Pediatrics and Infectious Diseases, Necker-Enfants Malades University Hospital, AP-HP, Paris Descartes University, Sorbonne Paris Cité, Paris, France
| | - Martin Castelle
- Pediatric Hematology-Immunology Unit, Necker-Enfants Malades University Hospital, AP-HP, Paris Descartes University, Sorbonne Paris Cité, Paris, France
| | - Florence Moulin
- Department of Pediatric Intensive Care Unit, Necker-Enfants Malades Hospital, AP-HP, Paris, France
| | - Xavier Nassif
- Department of Clinical Microbiology, Necker-Enfants Malades University Hospital, AP-HP, Paris Descartes University, Sorbonne Paris Cité, Paris, France
| | - Olivier Lortholary
- Necker-Pasteur Center for Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, AP-HP, Paris Descartes University, Sorbonne Paris Cité, Paris, France
| | - Martin Chalumeau
- Department of General Pediatrics and Infectious Diseases, Necker-Enfants Malades University Hospital, AP-HP, Paris Descartes University, Sorbonne Paris Cité, Paris, France
| | - Julie Toubiana
- Department of General Pediatrics and Infectious Diseases, Necker-Enfants Malades University Hospital, AP-HP, Paris Descartes University, Sorbonne Paris Cité, Paris, France.,Necker-Pasteur Center for Infectious Diseases and Tropical Medicine, Necker-Enfants Malades University Hospital, AP-HP, Paris Descartes University, Sorbonne Paris Cité, Paris, France
| |
Collapse
|
28
|
Alby-Laurent F, Lambe C, Ferroni A, Salvi N, Lebeaux D, Moulin F, Nassif X, Lortholary O, Chalumeau M, Toubiana J. Traitement conservateur des infections à Staphylococcus aureus liées aux cathéters veineux centraux de longue durée en pédiatrie. Med Mal Infect 2017. [DOI: 10.1016/j.medmal.2017.03.270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
29
|
Antona D, Kossorotoff M, Schuffenecker I, Mirand A, Leruez-Ville M, Bassi C, Aubart M, Moulin F, Lévy-Bruhl D, Henquell C, Lina B, Desguerre I. Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016. ACTA ACUST UNITED AC 2017; 21. [PMID: 27918268 PMCID: PMC5144948 DOI: 10.2807/1560-7917.es.2016.21.46.30402] [Citation(s) in RCA: 65] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2016] [Accepted: 11/17/2016] [Indexed: 11/20/2022]
Abstract
We report 59 cases of severe paediatric conditions linked with enterovirus (EV)-A71 and EV-D68 in France between May and October 2016. Fifty-two children had severe neurological symptoms. EV sequence-based typing for 42 cases revealed EV-A71 in 21 (18 subgenotype C1, detected for the first time in France) and EV-D68 in eight. Clinicians should be encouraged to obtain stool and respiratory specimens from patients presenting with severe neurological disorders for EV detection and characterisation.
Collapse
Affiliation(s)
- Denise Antona
- Direction des maladies infectieuses, Santé publique France, Saint-Maurice, France
| | - Manoëlle Kossorotoff
- Service de neuropédiatrie, AP-HP, Hôpital Necker - Enfants malades, Paris, France
| | - Isabelle Schuffenecker
- CNR des entérovirus et parechovirus, laboratoire de virologie, Hospices civils de Lyon, Lyon, France
| | - Audrey Mirand
- CNR des entérovirus et parechovirus-laboratoire associé, laboratoire de virologie, CHU de Clermont-Ferrand, Clermont Ferrand, France
| | | | - Clément Bassi
- Cellule d'intervention en région Ile de France, Santé publique France, Paris, France
| | - Mélodie Aubart
- Service de neuropédiatrie, AP-HP, Hôpital Necker - Enfants malades, Paris, France
| | - Florence Moulin
- Service de réanimation pédiatrique, AP-HP, Hôpital Necker - Enfants malades, Paris, France
| | - Daniel Lévy-Bruhl
- Direction des maladies infectieuses, Santé publique France, Saint-Maurice, France
| | - Cécile Henquell
- CNR des entérovirus et parechovirus-laboratoire associé, laboratoire de virologie, CHU de Clermont-Ferrand, Clermont Ferrand, France
| | - Bruno Lina
- CNR des entérovirus et parechovirus, laboratoire de virologie, Hospices civils de Lyon, Lyon, France
| | - Isabelle Desguerre
- Service de neuropédiatrie, AP-HP, Hôpital Necker - Enfants malades, Paris, France
| |
Collapse
|
30
|
Lacaille F, Irtan S, Dupic L, Talbotec C, Lesage F, Colomb V, Salvi N, Moulin F, Sauvat F, Aigrain Y, Revillon Y, Goulet O, Chardot C. Twenty-eight years of intestinal transplantation in Paris: experience of the oldest European center. Transpl Int 2017; 30:178-186. [DOI: 10.1111/tri.12894] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2016] [Revised: 10/31/2016] [Accepted: 11/20/2016] [Indexed: 01/19/2023]
Affiliation(s)
- Florence Lacaille
- Pediatric Gastroenterology-Hepatology-Nutrition; Necker-Enfants malades Hospital; Paris France
| | - Sabine Irtan
- Pediatric Surgery; Necker-Enfants malades Hospital; Paris France
| | - Laurent Dupic
- Pediatric Intensive Care; Necker-Enfants malades Hospital; Paris France
| | - Cécile Talbotec
- Pediatric Gastroenterology-Hepatology-Nutrition; Necker-Enfants malades Hospital; Paris France
| | - Fabrice Lesage
- Pediatric Intensive Care; Necker-Enfants malades Hospital; Paris France
| | - Virinie Colomb
- Pediatric Gastroenterology-Hepatology-Nutrition; Necker-Enfants malades Hospital; Paris France
| | - Nadège Salvi
- Anesthesiology; Necker-Enfants malades Hospital; Paris France
| | - Florence Moulin
- Pediatric Intensive Care; Necker-Enfants malades Hospital; Paris France
| | | | - Yves Aigrain
- Pediatric Surgery; Necker-Enfants malades Hospital; Paris France
| | - Yann Revillon
- Pediatric Surgery; Necker-Enfants malades Hospital; Paris France
| | - Olivier Goulet
- Pediatric Gastroenterology-Hepatology-Nutrition; Necker-Enfants malades Hospital; Paris France
| | | |
Collapse
|
31
|
Fanna M, Baptiste A, Capito C, Ortego R, Pacifico R, Lesage F, Moulin F, Debray D, Sissaoui S, Girard M, Lacaille F, Telion C, Elie C, Aigrain Y, Chardot C. Preoperative risk factors for intra-operative bleeding in pediatric liver transplantation. Pediatr Transplant 2016; 20:1065-1071. [PMID: 27681842 DOI: 10.1111/petr.12794] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 08/08/2016] [Indexed: 12/20/2022]
Abstract
This study analyzes the preoperative risk factors for intra-operative bleeding in our recent series of pediatric LTs. Between November 2009 and November 2014, 84 consecutive isolated pediatric LTs were performed in 81 children. Potential preoperative predictive factors for bleeding, amount of intra-operative transfusions, postoperative course, and outcome were recorded. Cutoff point for intra-operative HBL was defined as intra-operative RBC transfusions ≥1 TBV. Twenty-six patients (31%) had intra-operative HBL. One-year patient survival after LT was 66.7% (CI 95%=[50.2-88.5]) in HBL patients and 83.8% (CI 95%=[74.6-94.1]) in the others (P=.054). Among 13 potential preoperative risk factors, three of them were identified as independent predictors of high intra-operative bleeding: abdominal surgical procedure(s) prior to LT, factor V level ≤30% before transplantation, and ex situ parenchymal transsection of the liver graft. Based on these findings, we propose a simple score to predict the individual hemorrhagic risk related to each patient and graft association. This score may help to better anticipate intra-operative bleeding and improve patient's management.
Collapse
Affiliation(s)
- Martina Fanna
- Pediatric surgery unit, Hôpital Necker enfants malades, Paris, France
| | - Amandine Baptiste
- Clinical research unit, Hôpital Necker enfants malades, Paris, France
| | - Carmen Capito
- Pediatric surgery unit, Hôpital Necker enfants malades, Paris, France
| | - Rocio Ortego
- Anesthesiology unit, Hôpital Necker enfants malades, Paris, France
| | | | - Fabrice Lesage
- Intensive care unit, Hôpital Necker enfants malades, Paris, France
| | - Florence Moulin
- Intensive care unit, Hôpital Necker enfants malades, Paris, France
| | | | - Samira Sissaoui
- Hepatology unit, Hôpital Necker enfants malades, Paris, France
| | - Muriel Girard
- Hepatology unit, Hôpital Necker enfants malades, Paris, France
| | | | - Caroline Telion
- Anesthesiology unit, Hôpital Necker enfants malades, Paris, France
| | - Caroline Elie
- Clinical research unit, Hôpital Necker enfants malades, Paris, France
| | - Yves Aigrain
- Pediatric surgery unit, Hôpital Necker enfants malades, Paris, France
| | | |
Collapse
|
32
|
Matura-Bedouhene M, Maatouk A, Moulin F, Welter E, Morel O, Perdriolle-Galet E. [Pregnancy in patients with a history of ischaemic heart disease - Case series and literature review]. J Gynecol Obstet Hum Reprod 2016; 45:407-413. [PMID: 26321610 DOI: 10.1016/j.jgyn.2015.06.031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2015] [Revised: 06/08/2015] [Accepted: 06/18/2015] [Indexed: 06/04/2023]
Abstract
Heart diseases complicate 1 to 3% of pregnancies and are the leading cause of indirect maternal deaths. Prior ischaemic heart event in pregnant patients is increasing. Most knowledge is based on few reports and there are no French nor international recommendations about the specific management of these patients. The specificity of the management of these patients during pregnancy, delivery and post-partum depends on the severity of the prior cardiac event and its consequences. This will be illustrated by the report of four recent cases managed in our hospital. First patient had myocardial infarction with normal left ventricular ejection fraction (LVEF). Second patient had a Tako-Tsubo syndrome with LVEF 45%. Third patient had ischemic cardiopathy with LVEF 30%. Fourth patient had myocardial infarction with LVEF 20%. A multidisciplinary follow-up should be required, especially in patients with severe ventricular dysfunction. The risk of fetal growth restriction appears to be increased, suggesting that closer ultrasound monitoring is necessary.
Collapse
Affiliation(s)
- M Matura-Bedouhene
- Service de gynécologie-obstétrique, maternité régionale universitaire, 10, rue du Docteur-Heydenreich, 54000 Nancy, France.
| | - A Maatouk
- Service de gynécologie-obstétrique, CHR de Metz-Thionville, 1-3, rue du Friscaty, 57100 Thionville, France; Service de gynécologie-obstétrique, centre hospitalier Saint-Charles, 1, cours Raymond-Poincaré, 54520 Toul, France.
| | - F Moulin
- Institut Lorrain du cœur et des vaisseaux, 5, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France.
| | - E Welter
- Service de gynécologie-obstétrique, CHR de Metz-Thionville, 1-3, rue du Friscaty, 57100 Thionville, France.
| | - O Morel
- Service de gynécologie-obstétrique, maternité régionale universitaire, 10, rue du Docteur-Heydenreich, 54000 Nancy, France; Inserm U947, laboratoire IADI, 54500 Vandœuvre-lès-Nancy, France.
| | - E Perdriolle-Galet
- Service de gynécologie-obstétrique, maternité régionale universitaire, 10, rue du Docteur-Heydenreich, 54000 Nancy, France; Inserm U947, laboratoire IADI, 54500 Vandœuvre-lès-Nancy, France.
| |
Collapse
|
33
|
Tong L, Huang C, Ramalli A, Tortoli P, Luo J, D'hooge J, Tzemos N, Mordi I, Bishay T, Bishay T, Negishi T, Hristova K, Kurosawa K, Bansal M, Thavendiranathan P, Yuda S, Popescu B, Vinereanu D, Penicka M, Marwick T, Hamed W, Kamel M, Yaseen R, El-Barbary H, Nemes A, Kis O, Gavaller H, Kanyo E, Forster T, Angelis A, Vlachopoulos C, Ioakimidis N, Felekos I, Chrysohoou C, Aznaouridis K, Abdelrasoul M, Terentes D, Ageli K, Stefanadis C, Kurnicka K, Domienik-Karlowicz J, Lichodziejewska B, Goliszek S, Grudzka K, Krupa M, Dzikowska-Diduch O, Ciurzynski M, Pruszczyk P, Gual Capllonch F, Lopez Ayerbe J, Teis A, Ferrer E, Vallejo N, Junca G, Pla R, Bayes-Genis A, Schwaiger J, Knight D, Gallimore A, Schreiber B, Handler C, Coghlan J, Bruno RM, Giardini G, Malacrida S, Catuzzo B, Armenia S, Brustia R, Ghiadoni L, Cauchy E, Pratali L, Kim K, Lee K, Cho J, Yoon H, Ahn Y, Jeong M, Cho J, Park J, Cho S, Nastase O, Enache R, Mateescu A, Botezatu D, Popescu B, Ginghina C, Gu H, Sinha M, Simpson J, Chowienczyk P, Fazlinezhad A, Tashakori Behesthi A, Homaei F, Mostafavi H, Hosseini G, Bakaeiyan M, Boutsikou M, Petrou E, Dimopoulos A, Dritsas A, Leontiadis E, Karatasakis G, Sahin ST, Yurdakul S, Yilmaz N, Cengiz B, Cagatay Y, Aytekin S, Yavuz S, Karlsen S, Dahlslett T, Grenne B, Sjoli B, Smiseth O, Edvardsen T, Brunvand H, Nasr G, Nasr A, Eleraki A, Elrefai S, Mordi I, Sonecki P, Tzemos N, Gustafsson U, Naar J, Stahlberg M, Cerne A, Capotosto L, Rosato E, D'angeli I, Azzano A, Truscelli G, De Maio M, Salsano F, Terzano C, Mangieri E, Vitarelli A, Renard S, Najih H, Mancini J, Jacquier A, Haentjens J, Gaubert J, Habib G, Caminiti G, D'antoni V, D'antoni V, Cardaci V, Cardaci V, Conti V, Conti V, Volterrani M, Volterrani M, Ahn J, Kim D, Lee H, Iliuta L, Lo Iudice F, Esposito R, Lembo M, Santoro C, Ballo P, Mondillo S, De Simone G, Galderisi M, Hwang Y, Kim J, Kim J, Moon K, Yoo K, Kim C, Tagliamonte E, Rigo F, Cirillo T, Caruso A, Astarita C, Cice G, Quaranta G, Romano C, Capuano N, Calabro' R, Zagatina A, Zhuravskaya N, Guseva O, Huttin O, Benichou M, Voilliot D, Venner C, Micard E, Girerd N, Sadoul N, Moulin F, Juilliere Y, Selton-Suty C, Baron T, Christersson C, Johansson K, Flachskampf F, Lee S, Lee J, Hur S, Park J, Yun J, Song S, Kim W, Ko J, Nyktari E, Bilal S, Ali S, Izgi C, Prasad S, Aly M, Kleijn S, Kandil H, Kamp O, Beladan C, Calin A, Rosca M, Craciun A, Gurzun M, Calin C, Enache R, Mateescu A, Ginghina C, Popescu B, Mornos C, Mornos A, Ionac A, Cozma D, Crisan S, Popescu I, Ionescu G, Petrescu L, Camacho S, Gamaza Chulian S, Carmona R, Diaz E, Giraldez A, Gutierrez A, Toro R, Benezet J, Antonini-Canterin F, Vriz O, La Carrubba S, Poli S, Leiballi E, Zito C, Careri S, Caruso R, Pellegrinet M, Nicolosi G, Kong W, Kyu K, Wong R, Tay E, Yip J, Yeo T, Poh K, Correia M, Delgado A, Marmelo B, Correia E, Abreu L, Cabral C, Gama P, Santos O, Rahman M, Borges IP, Peixoto E, Peixoto R, Peixoto R, Marcolla V, Okura H, Kanai M, Murata E, Kataoka T, Stoebe S, Tarr A, Pfeiffer D, Hagendorff A, Generati G, Bandera F, Pellegrino M, Alfonzetti E, Labate V, Guazzi M, Kuznetsov V, Yaroslavskaya E, Pushkarev G, Krinochkin D, Zyrianov I, Carigi S, Baldazzi F, Bologna F, Amati S, Venturi P, Grosseto D, Biagetti C, Fabbri E, Arlotti M, Piovaccari G, Rahbi H, Bin Abdulhaq A, Tleyjeh I, Santoro C, Galderisi M, Costantino M, Tarsia G, Innelli P, Dores E, Esposito G, Matera A, De Simone G, Trimarco B, Capotosto L, Azzano A, Mukred K, Ashurov R, Tanzilli G, Mangieri E, Vitarelli A, Merlo M, Gigli M, Stolfo D, Pinamonti B, Antonini Canterin F, Muca M, D'angelo G, Scapol S, Di Nucci M, Sinagra G, Behaghel A, Feneon D, Fournet M, Thebault C, Martins R, Mabo P, Leclercq C, Daubert C, Donal E, Davinder Pal S, Prakash Chand N, Sanjeev A, Rajeev M, Ankur D, Ram Gopal S, Mzoughi K, Zairi I, Jabeur M, Ben Moussa F, Ben Chaabene A, Kamoun S, Mrabet K, Fennira S, Zargouni A, Kraiem S, Demkina A, Hashieva F, Krylova N, Kovalevskaya E, Potehkina N, Zaroui A, Ben Said R, Smaali S, Rekik B, Ben Hlima M, Mizouni H, Mechmeche R, Mourali M, Malhotra A, Sheikh N, Dhutia H, Siva A, Narain R, Merghani A, Millar L, Walker M, Sharma S, Papadakis M, Siam-Tsieu V, Mansencal N, Arslan M, Deblaise J, Dubourg O, Zaroui A, Rekik B, Ben Said R, Boudiche S, Larbi N, Tababi N, Hannachi S, Mechmeche R, Mourali M, Mechmeche R, Zaroui A, Chalbia T, Ben Halima M, Rekik B, Boussada R, Mourali M, Lipari P, Bonapace S, Valbusa F, Rossi A, Zenari L, Lanzoni L, Targher G, Canali G, Molon G, Barbieri E, Novo G, Giambanco S, Sutera M, Bonomo V, Giambanco F, Rotolo A, Evola S, Assennato P, Novo S, Budnik M, Piatkowski R, Kochanowski J, Opolski G, Chatzistamatiou E, Mpampatseva Vagena I, Manakos K, Moustakas G, Konstantinidis D, Memo G, Mitsakis O, Kasakogias A, Syros P, Kallikazaros I, Marketou M, Parthenakis F, Kalyva N, Pontikoglou C, Maragkoudakis S, Zacharis E, Patrianakos A, Maragoudakis F, Papadaki H, Vardas P, Rodrigues A, Perandini L, Souza T, Sa-Pinto A, Borba E, Arruda A, Furtado M, Carvalho F, Bonfa E, Andrade J, Hlubocka Z, Malinova V, Palecek T, Danzig V, Kuchynka P, Dostalova G, Zeman J, Linhart A, Chatzistamatiou E, Konstantinidis D, Memo G, Mpampatzeva Vagena I, Moustakas G, Manakos K, Trachanas K, Vergi N, Feretou A, Kallikazaros I, Corut H, Sade L, Ozin B, Atar I, Turgay O, Muderrisoglu H, Ledakowicz-Polak A, Polak L, Krauza G, Zielinska M, Szulik M, Streb W, Wozniak A, Lenarczyk R, Sliwinska A, Kalarus Z, Kukulski T, Nogueira M, Branco L, Agapito A, Galrinho A, Borba A, Teixeira P, Monteiro A, Ramos R, Cacela D, Cruz Ferreira R, Guala A, Camporeale C, Tosello F, Canuto C, Ridolfi L, Chatzistamatiou E, Moustakas G, Memo G, Konstantinidis D, Mpampatzeva Vagena I, Manakos K, Traxanas K, Vergi N, Feretou A, Kallikazaros I, Hristova K, Marinov R, Stamenov G, Mihova M, Persenska S, Racheva A, Plaskota K, Trojnarska O, Bartczak A, Grajek S, Ramush Bejiqi R, Retkoceri R, Bejiqi H, Beha A, Surdulli S, Dreyfus J, Durand-Viel G, Cimadevilla C, Brochet E, Vahanian A, Messika-Zeitoun D, Jin C, Fang F, Meng F, Kam K, Sun J, Tsui G, Wong K, Wan S, Yu C, Lee A, Cho IJ, Chung H, Heo R, Ha S, Hong G, Shim C, Chang H, Ha J, Chung N, Moral S, Gruosso D, Galuppo V, Teixido G, Rodriguez-Palomares J, Gutierrez L, Evangelista A, Moral S, Gruosso D, Galuppo V, Teixido G, Rodriguez-Palomares J, Gutierrez L, Evangelista A, Moral S, Gruosso D, Galuppo V, Teixido G, Rodriguez-Palomares J, Gutierrez L, Evangelista A, Alexopoulos A, Dawson D, Nihoyannopoulos P, Zainal Abidin HA, Ismail J, Arshad K, Ibrahim Z, Lim C, Abd Rahman E, Kasim S, Peteiro J, Barrio A, Escudero A, Bouzas-Mosquera A, Yanez J, Martinez D, Castro-Beiras A, Scali M, Simioniuc A, Mandoli G, Lombardo A, Massaro F, Di Bello V, Marzilli M, Dini F, Adachi H, Tomono J, Oshima S, Merchan Ortega G, Bravo Bustos D, Lazaro Garcia R, Sanchez Espino A, Macancela Quinones J, Ikuta I, Ruiz Lopez M, Valencia Serrano F, Bonaque Gonzalez J, Gomez Recio M, Romano G, D'ancona G, Pilato G, Di Gesaro G, Clemenza F, Raffa G, Scardulla C, Sciacca S, Lancellotti P, Pilato M, Addetia K, Takeuchi M, Maffessanti F, Weinert L, Hamilton J, Mor-Avi V, Lang R, Sugano A, Seo Y, Watabe H, Kakefuda Y, Aihara H, Nishina H, Ishizu T, Fumikura Y, Noguchi Y, Aonuma K, Luo X, Fang F, Lee A, Shang Q, Yu C, Sammut EC, Chabinok R, Jackson T, Siarkos M, Lee L, Carr-White G, Rajani R, Kapetanakis S, Byrne D, Walsh J, Ellis L, Mckiernan S, Norris S, King G, Murphy R, Hristova K, Katova T, Simova I, Kostova V, Shuie I, Ferferieva V, Bogdanova V, Castelon X, Nemes A, Sasi V, Domsik P, Kalapos A, Lengyel C, Orosz A, Forster T, Grapsa J, Demir O, Dawson D, Sharma R, Senior R, Nihoyannopoulos P, Pilichowska E, Zaborska B, Baran J, Stec S, Kulakowski P, Budaj A, Kosmala W, Kaye G, Saito M, Negishi K, Marwick T, Maceira Gonzalez AM, Ripoll C, Cosin-Sales J, Igual B, Salazar J, Belloch V, Dulai RS, Taylor A, Gupta S. Poster session 1: Wednesday 3 December 2014, 09:00-16:00 * Location: Poster area. Eur Heart J Cardiovasc Imaging 2014; 15:ii25-ii51. [DOI: 10.1093/ehjci/jeu248] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 09/02/2023] Open
|
34
|
Cristancho-Lacroix V, Moulin F, Wrobel J, Batrancourt B, Plichart M, De Rotrou J, Cantegreil-Kallen I, Rigaud AS. A web-based program for informal caregivers of persons with Alzheimer's disease: an iterative user-centered design. JMIR Res Protoc 2014; 3:e46. [PMID: 25263541 PMCID: PMC4180326 DOI: 10.2196/resprot.3607] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2014] [Revised: 07/24/2014] [Accepted: 07/25/2014] [Indexed: 11/13/2022] Open
Abstract
BACKGROUND Web-based programs have been developed for informal caregivers of people with Alzheimer's disease (PWAD). However, these programs can prove difficult to adopt, especially for older people, who are less familiar with the Internet than other populations. Despite the fundamental role of usability testing in promoting caregivers' correct use and adoption of these programs, to our knowledge, this is the first study describing this process before evaluating a program for caregivers of PWAD in a randomized clinical trial. OBJECTIVE The objective of the study was to describe the development process of a fully automated Web-based program for caregivers of PWAD, aiming to reduce caregivers' stress, and based on the user-centered design approach. METHODS There were 49 participants (12 health care professionals, 6 caregivers, and 31 healthy older adults) that were involved in a double iterative design allowing for the adaptation of program content and for the enhancement of website usability. This process included three component parts: (1) project team workshops, (2) a proof of concept, and (3) two usability tests. The usability tests were based on a mixed methodology using behavioral analysis, semistructured interviews, and a usability questionnaire. RESULTS The user-centered design approach provided valuable guidelines to adapt the content and design of the program, and to improve website usability. The professionals, caregivers (mainly spouses), and older adults considered that our project met the needs of isolated caregivers. Participants underlined that contact between caregivers would be desirable. During usability observations, the mistakes of users were also due to ergonomics issues from Internet browsers and computer interfaces. Moreover, negative self-stereotyping was evidenced, when comparing interviews and results of behavioral analysis. CONCLUSIONS Face-to-face psycho-educational programs may be used as a basis for Web-based programs. Nevertheless, a user-centered design approach involving targeted users (or their representatives) remains crucial for their correct use and adoption. For future user-centered design studies, we recommend to involve end-users from preconception stages, using a mixed research method in usability evaluations, and implementing pilot studies to evaluate acceptability and feasibility of programs.
Collapse
Affiliation(s)
- Victoria Cristancho-Lacroix
- Assistance Publique des Hôpitaux de Paris (APHP), Hôpital Broca, Service de Gérontologie, Pôle de Gériatrie, Paris, France.
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Aguilar C, Malphettes M, Donadieu J, Chandesris O, Coignard-Biehler H, Catherinot E, Pellier I, Stephan JL, Le Moing V, Barlogis V, Suarez F, Gérart S, Lanternier F, Jaccard A, Consigny PH, Moulin F, Launay O, Lecuit M, Hermine O, Oksenhendler E, Picard C, Blanche S, Fischer A, Mahlaoui N, Lortholary O. Prevention of infections during primary immunodeficiency. Clin Infect Dis 2014; 59:1462-70. [PMID: 25124061 DOI: 10.1093/cid/ciu646] [Citation(s) in RCA: 65] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
Because infectious diseases are a major source of morbidity and mortality in the majority of patients with primary immunodeficiencies (PIDs), the application of a prophylactic regimen is often necessary. However, because of the variety of PIDs and pathogens involved, and because evidence is scarce, practices are heterogeneous. To homogenize practices among centers, the French National Reference Center for PIDs aimed at elaborating recommendations for anti-infectious prophylaxis for the most common PIDs. We performed a literature review of infectious complications and prophylactic regimens associated with the most frequent PIDs. Then, a working group including different specialists systematically debated about chemoprophylaxis, immunotherapy, immunization, and recommendations for patients. Grading of prophylaxis was done using strength of recommendations (decreasing from A to D) and evidence level (decreasing from I to III). These might help infectious diseases specialists in the management of PIDs and improving the outcome of patients with PIDs.
Collapse
Affiliation(s)
- Claire Aguilar
- Centre de Référence des Déficits Immunitaires Héréditaires Centre d'Infectiologie Necker Pasteur, Hôpital Necker-Enfants Malades, Assistance publique-Hôpitaux de Paris (AP-HP) Sorbonne Paris Cité, Université Paris Descartes, Institut-Hospitalo-Universitaire (IHU) Imagine
| | - Marion Malphettes
- Centre de Référence des Déficits Immunitaires Héréditaires Département d'Immunologie, Hôpital Saint-Louis
| | - Jean Donadieu
- Centre de Référence des Déficits Immunitaires Héréditaires Service d'Hémato-Oncologie Pédiatrique, Registre des Neutropénies Congénitales, Hôpital Trousseau
| | - Olivia Chandesris
- Centre de Référence des Déficits Immunitaires Héréditaires Sorbonne Paris Cité, Université Paris Descartes, Institut-Hospitalo-Universitaire (IHU) Imagine Service d'Hématologie Adulte, IHU Imagine, Hôpital Necker-Enfants Malades, AP-HP, Paris
| | - Hélène Coignard-Biehler
- Centre de Référence des Déficits Immunitaires Héréditaires Centre d'Infectiologie Necker Pasteur, Hôpital Necker-Enfants Malades, Assistance publique-Hôpitaux de Paris (AP-HP) Sorbonne Paris Cité, Université Paris Descartes, Institut-Hospitalo-Universitaire (IHU) Imagine
| | - Emilie Catherinot
- Centre de Référence des Déficits Immunitaires Héréditaires Service de Pneumologie, Hôpital Foch, Suresnes
| | - Isabelle Pellier
- Centre de Référence des Déficits Immunitaires Héréditaires Unité d'Immuno-Hématologie-Oncologie Pédiatrique, Centre Hospitalier Universitaire (CHU) d'Angers
| | - Jean-Louis Stephan
- Centre de Référence des Déficits Immunitaires Héréditaires Unité d'Immuno-Hématologie-Oncologie Pédiatrique, CHU de Saint-Etienne
| | - Vincent Le Moing
- Centre de Référence des Déficits Immunitaires Héréditaires Service des Maladies Infectieuses et Tropicales, CHU de Montpellier
| | - Vincent Barlogis
- Centre de Référence des Déficits Immunitaires Héréditaires Service d'Hématologie Pédiatrique, Hôpital de la Timone, AP-HM, Marseille
| | - Felipe Suarez
- Centre de Référence des Déficits Immunitaires Héréditaires Sorbonne Paris Cité, Université Paris Descartes, Institut-Hospitalo-Universitaire (IHU) Imagine Service d'Hématologie Adulte, IHU Imagine, Hôpital Necker-Enfants Malades, AP-HP, Paris
| | - Stéphane Gérart
- Sorbonne Paris Cité, Université Paris Descartes, Institut-Hospitalo-Universitaire (IHU) Imagine
| | - Fanny Lanternier
- Centre de Référence des Déficits Immunitaires Héréditaires Centre d'Infectiologie Necker Pasteur, Hôpital Necker-Enfants Malades, Assistance publique-Hôpitaux de Paris (AP-HP) Sorbonne Paris Cité, Université Paris Descartes, Institut-Hospitalo-Universitaire (IHU) Imagine
| | - Arnaud Jaccard
- Centre de Référence des Déficits Immunitaires Héréditaires Département d'Hématologie, CHU Dupuytren, Limoges
| | - Paul-Henri Consigny
- Centre d'Infectiologie Necker Pasteur, Hôpital Necker-Enfants Malades, Assistance publique-Hôpitaux de Paris (AP-HP)
| | - Florence Moulin
- Service des Soins Continus de Chirurgie, Hôpital Necker-Enfants Malades, AP-HP
| | - Odile Launay
- Sorbonne Paris Cité, Université Paris Descartes, CIC Vaccinologie Cochin-Pasteur
| | - Marc Lecuit
- Centre de Référence des Déficits Immunitaires Héréditaires Centre d'Infectiologie Necker Pasteur, Hôpital Necker-Enfants Malades, Assistance publique-Hôpitaux de Paris (AP-HP) Sorbonne Paris Cité, Université Paris Descartes, Institut-Hospitalo-Universitaire (IHU) Imagine
| | - Olivier Hermine
- Centre de Référence des Déficits Immunitaires Héréditaires Sorbonne Paris Cité, Université Paris Descartes, Institut-Hospitalo-Universitaire (IHU) Imagine Service d'Hématologie Adulte, IHU Imagine, Hôpital Necker-Enfants Malades, AP-HP, Paris
| | - Eric Oksenhendler
- Centre de Référence des Déficits Immunitaires Héréditaires Département d'Immunologie, Hôpital Saint-Louis
| | - Capucine Picard
- Centre de Référence des Déficits Immunitaires Héréditaires Sorbonne Paris Cité, Université Paris Descartes, Institut-Hospitalo-Universitaire (IHU) Imagine Centre d'Étude des Déficits Immunitaires Primitifs, Hôpital Necker-Enfants Malades, AP-HP Unité d'Immunologie et Hématologie Pédiatrique, IHU Imagine, Hôpital Necker-Enfants Malades
| | - Stéphane Blanche
- Centre de Référence des Déficits Immunitaires Héréditaires Sorbonne Paris Cité, Université Paris Descartes, Institut-Hospitalo-Universitaire (IHU) Imagine Unité d'Immunologie et Hématologie Pédiatrique, IHU Imagine, Hôpital Necker-Enfants Malades
| | - Alain Fischer
- Centre de Référence des Déficits Immunitaires Héréditaires Sorbonne Paris Cité, Université Paris Descartes, Institut-Hospitalo-Universitaire (IHU) Imagine Unité d'Immunologie et Hématologie Pédiatrique, IHU Imagine, Hôpital Necker-Enfants Malades Collège de France, Paris, France
| | - Nizar Mahlaoui
- Centre de Référence des Déficits Immunitaires Héréditaires Sorbonne Paris Cité, Université Paris Descartes, Institut-Hospitalo-Universitaire (IHU) Imagine Unité d'Immunologie et Hématologie Pédiatrique, IHU Imagine, Hôpital Necker-Enfants Malades
| | - Olivier Lortholary
- Centre de Référence des Déficits Immunitaires Héréditaires Centre d'Infectiologie Necker Pasteur, Hôpital Necker-Enfants Malades, Assistance publique-Hôpitaux de Paris (AP-HP) Sorbonne Paris Cité, Université Paris Descartes, Institut-Hospitalo-Universitaire (IHU) Imagine
| |
Collapse
|
36
|
Lorrot M, Bourrat E, Doit C, Prot-Labarthe S, Dauger S, Faye A, Blondé R, Gillet Y, Grimprel E, Moulin F, Quinet B, Cohen R, Bonacorsi S. Infections superficielles de la peau et dermo-hypodermites bactériennes. Arch Pediatr 2014; 21:906-12. [DOI: 10.1016/j.arcped.2014.04.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2013] [Revised: 04/18/2014] [Accepted: 04/22/2014] [Indexed: 12/01/2022]
|
37
|
Rotenberg Brigot D, Quinet B, Moulin F, Aurel M, Carbajal R, de Suremain N. SFP P-091 - Place des conseils préventifs et morbidité chez l’enfant voyageur. Arch Pediatr 2014. [DOI: 10.1016/s0929-693x(14)72061-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
38
|
de Rotrou J, Wu YH, Mabire JB, Moulin F, de Jong LW, Rigaud AS, Hanon O, Vidal JS. Does cognitive function increase over time in the healthy elderly? PLoS One 2013; 8:e78646. [PMID: 24244332 PMCID: PMC3823862 DOI: 10.1371/journal.pone.0078646] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2013] [Accepted: 09/15/2013] [Indexed: 11/28/2022] Open
Abstract
BACKGROUND In dementia screening, most studies have focused on early cognitive impairment by comparing patients suffering from mild dementia or mild cognitive impairment with normal subjects. Few studies have focused on modifications over time of the cognitive function in the healthy elderly. The objective of the present study was to analyze the cognitive function changes of two different samples, born > 15 years apart. METHOD A first sample of 204 cognitively normal participants was recruited in the memory clinic of Broca hospital between 1991 and 1997. A second sample of 177 cognitively normal participants was recruited in 2008-2009 in the same institution. Both samples were from the same districts of Paris and were assessed with the same neuropsychological test battery. Mean cognitive test scores were compared between 1991 and 2008 samples, between < 80 years old and ≥ 80 years old in 1991 and 2008 samples, and finally between subjects < 80 year old of 1991 sample and subjects ≥ 80 years old of the 2008 sample. Means were compared with T-tests stratified on gender, age-groups and educational level. RESULTS Cognitive scores were significantly higher in the 2008 sample. Participants < 80 years old outperformed those ≥ 80 in both samples. However, participants < 80 years old in 1991 sample and subjects ≥ 80 in the 2008 sample, born on average in 1923, performed mostly identically. CONCLUSION This study showed a significant increase of cognitive scores over time. Further, contemporary octogenarians in the later sample performed like septuagenarians in the former sample. These findings might be consistent with the increase in life expectancy and life span in good health. The study highlights the necessity to take into account factors which may contaminate and artificially inflate the age-related differences in favor of younger to the older adults.
Collapse
Affiliation(s)
- Jocelyne de Rotrou
- Service de Gérontologie, Hôpital Broca, Assistance Publique-Hôpitaux de Paris, Paris, France
- Equipe d’Accueil 4468, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Ya-Huei Wu
- Service de Gérontologie, Hôpital Broca, Assistance Publique-Hôpitaux de Paris, Paris, France
- Equipe d’Accueil 4468, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Jean-Bernard Mabire
- Service de Gérontologie, Hôpital Broca, Assistance Publique-Hôpitaux de Paris, Paris, France
- Equipe d’Accueil 4430, Université Paris Ouest, Nanterre, France
| | - Florence Moulin
- Service de Gérontologie, Hôpital Broca, Assistance Publique-Hôpitaux de Paris, Paris, France
- Equipe d’Accueil 4468, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Laura W. de Jong
- Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands
| | - Anne-Sophie Rigaud
- Service de Gérontologie, Hôpital Broca, Assistance Publique-Hôpitaux de Paris, Paris, France
- Equipe d’Accueil 4468, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Olivier Hanon
- Service de Gérontologie, Hôpital Broca, Assistance Publique-Hôpitaux de Paris, Paris, France
- Equipe d’Accueil 4468, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Jean-Sébastien Vidal
- Service de Gérontologie, Hôpital Broca, Assistance Publique-Hôpitaux de Paris, Paris, France
- Equipe d’Accueil 4468, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| |
Collapse
|
39
|
Mahlaoui N, Moulin F, Launay O, Gaudelus J. Vaccination des patients ayant un déficit immunitaire héréditaire. Arch Pediatr 2013. [DOI: 10.1016/s0929-693x(13)71346-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
40
|
Faillon S, Martinot A, Hau I, Puget A, Moulin F, Noel G, Guen CGL, Lorrot M, Callamand P, Hue V, Meritet JF, Gendrel D, Dubos F. Impact of travel on the seroprevalence of hepatitis A in children. J Clin Virol 2013; 56:46-51. [DOI: 10.1016/j.jcv.2012.10.004] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2012] [Revised: 09/24/2012] [Accepted: 10/10/2012] [Indexed: 12/11/2022]
|
41
|
Leroy S, Romanello C, Smolkin V, Galetto-Lacour A, Korczowski B, Tuerlinckx D, Rodrigo C, Gajdos V, Moulin F, Pecile P, Halevy R, Gervaix A, Duhl B, Vander Borght T, Prat C, Foix-l'Hélias L, Altman DG, Gendrel D, Bréart G, Chalumeau M. Prediction of Moderate and High Grade Vesicoureteral Reflux After a First Febrile Urinary Tract Infection in Children: Construction and Internal Validation of a Clinical Decision Rule. J Urol 2012; 187:265-71. [PMID: 22100009 DOI: 10.1016/j.juro.2011.09.034] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2011] [Indexed: 11/26/2022]
Affiliation(s)
- Sandrine Leroy
- Center for Statistics in Medicine, University of Oxford, Oxford, United Kingdom
- INSERM U953, Université Paris-Descartes, Paris, France
- Department of Pediatrics, Necker Hospital, AP-HP, Université Paris-Descartes, Paris, France
| | | | | | | | - Bartosz Korczowski
- Department of Pediatrics, Regional Hospital No. 2, University of Rzeszow, Rzeszow, Poland
| | - David Tuerlinckx
- Department of Pediatrics, Cliniques Universitaires de Mont-Godinne, Université Catholique de Louvain, Yvoir, Belgium
| | - Carlos Rodrigo
- Department of Pediatrics, Germans Trias i Pujol Hospital, Autonomous University of Barcelona, Barcelona, Spain
| | - Vincent Gajdos
- INSERM U822, University Paris-Sud, Paris, France
- Department of Pediatrics, Antoine Béclère Hospital, Clamart, France
| | - Florence Moulin
- Department of Emergency Medicine, Saint-Vincent-de-Paul Hospital, AP-HP, Paris, France
| | - Paolo Pecile
- Department of Pediatrics, University of Udine, Udine, Italy
| | - Raphaël Halevy
- Department of Pediatrics, Ha'Emek Medical Center, Afula, Israel
| | - Alain Gervaix
- Department of Pediatrics, University Hospital of Geneva, Geneva, Switzerland
| | - Barbara Duhl
- Department of Pediatrics, University Hospital of Geneva, Geneva, Switzerland
| | - Thierry Vander Borght
- Department of Nuclear Medicine, Cliniques Universitaires de Mont-Godinne, Université Catholique de Louvain, Yvoir, Belgium
| | - Cristina Prat
- Department of Microbiology, Germans Trias i Pujol Hospital, Autonomous University of Barcelona, Barcelona, Spain
| | | | - Douglas G. Altman
- Center for Statistics in Medicine, University of Oxford, Oxford, United Kingdom
| | - Dominique Gendrel
- Department of Pediatrics, Necker Hospital, AP-HP, Université Paris-Descartes, Paris, France
| | - Gérard Bréart
- INSERM U953, Université Paris-Descartes, Paris, France
| | - Martin Chalumeau
- INSERM U953, Université Paris-Descartes, Paris, France
- Department of Pediatrics, Necker Hospital, AP-HP, Université Paris-Descartes, Paris, France
| |
Collapse
|
42
|
Moulin F, Ménager C. Le linézolide en pédiatrie. Arch Pediatr 2010; 17 Suppl 4:S133-9. [DOI: 10.1016/s0929-693x(10)70914-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
43
|
Imbert P, Moulin F, Mornand P, Méchaï F, Rapp C. [Should yellow fever vaccination be recommended during pregnancy or breastfeeding?]. Med Trop (Mars) 2010; 70:321-324. [PMID: 22368925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
Yellow fever vaccine is produced from a live attenuated virus that is contraindicated in case of immunodeficiency and subject to restrictions for pregnant or breastfeeding women. The purpose of this review of available information on yellow fever vaccination during pregnancy and breastfeeding is to assist physicians in making recommendations prior to departure to yellow-fever endemic zones. Regarding pregnancy, there is no evidence to support a major risk of yellow-fever-vaccine-related complications in mothers or children. Although this finding is reassuring, it should be underlined that most reported series have been small. Regarding breastfeeding, the risk was recently confirmed by a report describing vaccine-induced encephalitis occurring in an infant 8 days after primary vaccination of the mother. The final decision to vaccinate depends on whether or not the trip can be postponed. If travel is mandatory, vaccination may be recommended in pregnant women preferably during the first trimester since the immunological response appears to be better at that time. Antibody titer should be checked following delivery. During breastfeeding, vaccination may be performed but breastfeeding must be stopped during the postvaccinal viremia phase. Breastfeeding can be resumed after a 10-day period of formula feeding.
Collapse
Affiliation(s)
- P Imbert
- Service des maladies infectieuses et tropicales, Hôpital d'instruction des armies Bégin, Saint-Mandé.
| | | | | | | | | |
Collapse
|
44
|
Imbert P, Moulin F. Traitements antihelminthiques chez l’enfant. Arch Pediatr 2010; 17:840-1. [DOI: 10.1016/s0929-693x(10)70138-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
45
|
Blum M, Boehler M, Randall E, Young V, Csukai M, Kraus S, Moulin F, Scalliet G, Avrova AO, Whisson SC, Fonne-Pfister R. Mandipropamid targets the cellulose synthase-like PiCesA3 to inhibit cell wall biosynthesis in the oomycete plant pathogen, Phytophthora infestans. Mol Plant Pathol 2010; 11:227-43. [PMID: 20447272 PMCID: PMC6640402 DOI: 10.1111/j.1364-3703.2009.00604.x] [Citation(s) in RCA: 70] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/18/2023]
Abstract
Oomycete plant pathogens cause a wide variety of economically and environmentally important plant diseases. Mandipropamid (MPD) is a carboxylic acid amide (CAA) effective against downy mildews, such as Plasmopara viticola on grapes and potato late blight caused by Phytophthora infestans. Historically, the identification of the mode of action of oomycete-specific control agents has been problematic. Here, we describe how a combination of biochemical and genetic techniques has been utilized to identify the molecular target of MPD in P. infestans. Phytophthora infestans germinating cysts treated with MPD produced swelling symptoms typical of cell wall synthesis inhibitors, and these effects were reversible after washing with H(2)O. Uptake studies with (14)C-labelled MPD showed that this oomycete control agent acts on the cell wall and does not enter the cell. Furthermore, (14)C glucose incorporation into cellulose was perturbed in the presence of MPD which, taken together, suggests that the inhibition of cellulose synthesis is the primary effect of MPD. Laboratory mutants, insensitive to MPD, were raised by ethyl methane sulphonate (EMS) mutagenesis, and gene sequence analysis of cellulose synthase genes in these mutants revealed two point mutations in the PiCesA3 gene, known to be involved in cellulose synthesis. Both mutations in the PiCesA3 gene result in a change to the same amino acid (glycine-1105) in the protein. The transformation and expression of a mutated PiCesA3 allele was carried out in a sensitive wild-type isolate to demonstrate that the mutations in PiCesA3 were responsible for the MPD insensitivity phenotype.
Collapse
Affiliation(s)
- Mathias Blum
- Syngenta Crop Protection AG, CH-4332 Stein, Switzerland
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Abstract
Imported malaria is a disease prevalent in France: 6,000 to 8,000 cases a year, of which 15% are pediatric cases. Despite this high incidence, the diagnosis is often delayed. The patient may then evolve to a severe form. This diagnostic delay is due to non-specific clinical symptoms in children. The most common symptoms are fever and digestive disorders (diarrhea, vomiting). In the absence of thrombocytopenia, the laboratory tests are not very useful for diagnosis. Parasitological examinations are dependent on the experience of the biologist, particularly in cases of low parasitemia as those observed in children who have received partial chemoprophylaxis. The recent introduction of rapid tests based on the detection of Plasmodium proteins, allows emergency remedy to this problem. The blood smears remains the gold standard and has to be used to confirm the results of rapid tests. If rapid tests improve the detection of Plasmodium in 2009, it remains mandatory to evoke the diagnosis of malaria in any febrile child coming from an endemic area.
Collapse
Affiliation(s)
- F Moulin
- Université et Faculté de médecine PARIS 5, Hôpital Saint-Vincent de Paul-Cochin, 74 av Denfert-Rochereau, 75014 Paris
| | | |
Collapse
|
47
|
Imbert P, Moulin F. [XXIIIrd French-language North/South Pediatrics Conference]. Med Trop (Mars) 2009; 69:559-560. [PMID: 20099668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Affiliation(s)
- P Imbert
- Groupe de Pédiatrie tropicale de la Société Française de Pédiatrie.
| | | |
Collapse
|
48
|
Sorge F, Imbert P, Moulin F, Laurent C, Banerjee A, Guérin N, Gendrel D. Protection antimoustique chez l’enfant : recommandations du Groupe de Pédiatrie Tropicale. Arch Pediatr 2009; 16:771-3. [DOI: 10.1016/s0929-693x(09)74146-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
49
|
Sorge F, Guérin N, Imbert P, Gay F, Moulin F, Laurent C, Banerjee A, Khelfaoui F, Gendrel D. Facteurs limitant les vaccinations de l’enfant voyageur en France : l’exemple de l’hépatite A. Arch Pediatr 2009; 16:850-2. [DOI: 10.1016/s0929-693x(09)74177-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
50
|
Raymond J, Moulin F. Bactériologie des surinfections de la varicelle et conséquences thérapeutiques. Arch Pediatr 2009; 16:926-8. [DOI: 10.1016/s0929-693x(09)74206-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|